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Abstract 
Background: One form of attention suggested to be impaired in Multiple 
Sclerosis (MS) is divided attention (DA), or the ability to attend to more multiple tasks 
or streams of information simultaneously; also referred to as dual-tasking. The ability 
to dual-task is required for everyday situations including cognitive-motor 
combinations such as walking and talking. Several studies have reported a 
disproportionate difficulty in combining walking with cognitive tasks in people with 
MS. Various explanations for this difficulty have been proposed, with a DA deficit 
being one. Consequently, it is important to determine whether a DA deficit is evident 
in MS. Objective: To examine the literature that has investigated performance of 
people with Relapsing-Remitting MS on tasks of DA. Methods: Two hundred and 
fifteen potentially relevant articles were initially identified. Eight met inclusion criteria. 
Studies were rated using a methodological quality rating protocol developed from 
SIGN Methodology Checklists 3 and 4 and a narrative review was conducted. 
Results: Six of the eight included studies reported a DA deficit in the RRMS group in 
comparison to controls. Effect sizes were calculated for seven of the eight papers 
with a median effect size of 0.69. Several methodological limitations of included 
studies were identified. Conclusions: It was not possible to conclude that a DA 
deficit is evident in individuals with RRMS. This was due to varying methodologies of 
measures of DA, lack of adherence to a dual-task paradigm, and limited control for 
potential confounding variables across the included studies.   
 
Key words: Multiple Sclerosis, Divided Attention, Dual-Task  
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Introduction 
Worldwide, it is estimated that approximately 2,500,000 people have a 
diagnosis of Multiple Sclerosis (MS) [MS Trust, 2015]. MS is an autoimmune disease 
wherein the body’s immune system attacks the myelin sheath of nerves, resulting in 
scarring [Gontkovsky & Golden, 2008]. MS is characterised by progressive and 
changeable episodes of demyelination and transaction resulting in axonal damage 
and loss of neurons [Farooqui, 2011]. Enduring axonal and grey matter tissue 
damage, inter alia, can contribute to atrophy within the brain [De Stefano, Battaglini, 
& Smith, 2007]; this underlies neurological disability and associated loss of motor or 
cognitive functions [Fisher, Lee, Nakamura, & Rudick, 2008]. Variation in the amount 
of axonal damage and atrophy, as well as the locations of lesions in the brain, results 
in a wide variation in symptom presentation [McDonald et al., 2001]. Over the last 
decade, neuroimaging research has demonstrated loss of axons and cell bodies in 
very early stages of MS [DeLuca, Ebers, & Esiri, 2004; Davies et al., 2004]. 
Therefore, it is imperative to investigate associated impairment as early in the 
disease process as possible.  
There are three forms of MS that have differing disease courses: Relapsing-
Remitting (RRMS); Secondary Progressive (SPMS); and Primary Progressive 
(PPMS). Imaging and histopathological findings suggest that inflammation is 
dominant in the disease course of RRMS, whereas in SPMS and PPMS 
neurodegeneration predominates [Kuhlmann, 2013].  RRMS is characterised by 
episodes of acute worsening followed by partial or complete recovery. Conversely, 
SPMS and PPMS are characterised by unremitting worsening. RRMS is not only the 
most prevalent type of MS but the majority of individuals diagnosed with MS start 
with this disease course [Kuhlmann, 2013]. Consequently, this review focuses on the 
RRMS subtype.  
Cognitive impairment in MS is reported to occur in 40-65% of patients [Julian, 
2011]. Typically, impairments start early in the disease process, deteriorate over 
time, and are independent of physical disability [Julian, 2011]. Although there is not a 
consistent profile of cognitive impairment in MS, the cognitive domains most 
commonly affected in MS are memory, attention, executive functioning and 
information processing speed. This is a result of predominantly subcortical white 
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matter aetiology in the brain [DeSousa, Albert, & Kalman, 2002]. This review focuses 
on the domain of attention.  
One form of attention suggested to be impaired in MS is divided attention (DA) 
[Bobholz & Rao, 2003; Ferreira, 2010]. DA refers to the ability to attend to more than 
one task or stream information simultaneously; sometimes also referred to as dual-
tasking [Lezak, 1995]. The cognitive skill of DA is complex, utilising dedicated cortical 
areas which need reciprocal intact white matter connections. Axonal changes seen in 
MS make white matter connections vulnerable to damage. The common format for 
investigating dual-tasking involves tasks being carried out independently and then 
combined. In a number of groups (e.g. older adults and people with various 
neurological conditions) it has been shown that when two tasks are combined, the 
decrement in performance from single to dual-task conditions is greater than in 
healthy controls [Yang, Chen, Lee, Cheng, & Wang, 2007; Muir et al., 2012]. A 
particularly important everyday ‘dual-task’ is walking and talking. Several studies 
have found evidence for a disproportionate difficulty in combining walking with 
cognitive tasks in people with MS [Hamilton et al., 2009; Kalron, Dvir, & Achiron, 
2010]. There are several possible explanations for why walking and talking might be 
impaired; and these relate to theories of attentional control.  
Models of attentional control include Baddeley and Hitch’s Working Memory 
Model [Baddeley & Hitch, 1974; Baddeley, 1996]. The central executive of this model 
is viewed as an attentional controller. What is not explicit in this model is whether the 
central executive can divide attention between the two slave systems simultaneously 
or only move attention flexibly from one to another. Other recent models of working 
memory [Oberauer, 2002; Oberauer, 2009] describe models that have a focus of 
attention which has a capacity of one unit, suggesting that the focus of attention can 
only be on one thing at a time. This idea is consistent with theories of dual-task 
performance, including the response-selection bottleneck model [Pashler, 1994], 
which suggests the process of selecting a response to a stimulus can only attend to 
one unit at a time and therefore dual-task demands will create a cost compared to 
single task performance. Another explanation for dual-task decrements [Tsang, 2013] 
is resource theory, which suggests that resources needed for task processing are 
limited, and if the tasks demands are not met by sufficient supply of resources, 
performance degrades.  
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In relation to walking and talking in a condition such as MS, it would appear 
that there are several potential reasons why we might see disproportionate 
decrements. One is that there is a central problem with DA so that tasks cannot be 
combined. The other is a resource limitation issue - tasks such as walking demand 
much greater resources than usual and these demands outstrip the capacity of the 
system, particularly where there are additional cognitive demands [Hamilton et al., 
2009; Kalron et al., 2010]. It would therefore be useful to clarify whether a DA deficit 
is evident in MS, particularly in the early stages, and to examine whether there is 
evidence of a DA deficit on tasks that do not involve demanding motor tasks such as 
walking.  
The aim of this review therefore was to examine the literature that has 
investigated performance of people with RRMS on tasks of DA. This review asks 
three questions: (1) is there a DA deficit in RRMS; (2) what methods are used to 
measure DA in RRMS; and (3) if there is a DA deficit, is this evident early in the 
disease course? As part of this review, the nature of the tasks used, and 
characteristics of the participants (early/late stage MS) will be described and the 
methodological quality of the literature determined.  
 
Methods 
All studies that scrutinised performance of people with RRMS on tasks of DA 
were eligible for inclusion in this systematic review. Dynamed, UpToDate, BMJ Best 
Practice and the Cochrane Database of Systematic Reviews were searched with the 
term “Multiple Sclerosis”. No ongoing or accessible, meta-analyses, systematic or 
literature reviews focusing on this topic were found.  
 
Database Searches 
The search terms “divided attention” and “multiple sclerosis”, with Boolean 
operator ‘AND’ in-between, were applied to the title, abstract and index fields of 
databases. The following search platforms and databases were used: Medline (via 
OVID Medline (R) 1946 to week 1 January 2016 and OVID Medline (R) in-process & 
other non-indexed citations); Embase (via OVID Embase, 1947 to present, updated 
daily on 28th January 2016); CINAHL, PsycInfo, Psychology and Behavioural 
Sciences Collection and Biomedical Reference Collection: Comprehensive (via 
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EBSCOhost 1987 until 28th January 2016); Cochrane Library (inception date of 
database until 28th January 2016); Web of Science (inception date of database until 
28th January 2016). Subsequently, a hand search of the reference lists of included 
studies were examined to ensure no pertinent articles were missed from database 
searches.  
 
Study Selection 
Figure 1 outlines the search approach taken, number of references considered 
at each stage of the search process and exclusion criteria. Eight studies [Claros-
Salinas et al., 2013; Devos, Brijs, Alders, Wets, & Feys, 2013; McCarthy, Beaumont, 
Thompson, & Peacock, 2005; Patanella et al., 2010; Paul, Beatty, Schneider, Blanco, 
& Hames, 1998; Ruet, Deloire, Charre-Morin, Hamel, & Brochet, 2013; De Sonneville 
et al., 2002; Stoquart-ElSankari, Bottin, Roussel-Pieronne, & Godefroy, 2010] met 
the following inclusion criteria: (i) peer-reviewed articles published in English; (ii) 
human, adult participants (aged 18-65); (iii) original published research; (iv) 
participants have a diagnosis of RRMS; (v) presence of a control group; (vi) study 
provides a measure of DA as characterised by the study authors; and (vii) studies do 
not involve a complex motor task that requires balance and/or walking. If suitability 
for inclusion was ambiguous, an independent researcher examined the article.  
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Initial Electronic Search and Hand Search 
OVID    72
Medline; Ovid Medline; Embase
Web of Science    59
Cochrane Library       9
EbscoHOST    34
CINAHL Plus; PsycINFO; Psychology and 
Behavioural Sciences Collecion; Biomedical 
Reference Collection
Hand Search 41
(n = 215)
Included Articles (n = 8) 
Excluded (n = 22)
Lack measure of divided attention 
Qualitative study
Unable to get full text
Case group selected due to known deficit in attention
Type of MS not specified
Divided Attention task only completed by case group
Excluded (n = 94)
If dual-task, excluded those with motor component 
Lack of control group 
Excluded (n = 58)
Excluded by language 
Lack peer review (e.g. conference/meeting abstract)
Lack of MS population 
Paediatric population 
Older adult population (+65 years) 
Evaluation of intervention/treatment 
Unrelated to review topic 
Review of Full Articles (n = 30)
Review of Abstracts (n = 124)
Screening of Titles (n = 182)
Duplicates Removed (n = 33)
 
 
Figure 1: Article Search Strategy Flowchart   
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Quality Rating  
 A quality rating protocol was composed (appendix 1.2) based on the Scottish 
Intercollegiate Guidelines Network (SIGN) Methodology Checklists 3: Cohort Studies 
and 4: Case-control Studies [SIGN, 2007]. The protocol consists of 13 items 
separated into two sections that cover six methodological areas: study question, 
subject selection, assessment, confounding factors, statistical analysis and overall 
assessment. Each item in section one is answered with ‘yes’, ‘no’ or ‘can’t say’. 
Consistent with SIGN procedures, the overall methodological quality is rated as ‘high 
quality’ (++), ‘acceptable’ (+) or ‘low quality’ (0) based on the answers to the 10 items 
in section one. For the purposes of this review, a rating of ++ was given if the 
majority (seven or more) of the items in section one were answered ‘yes’; a rating of 
+ was given if most (five or six) of the items were answered ‘yes’; and a rating of ‘0’ is 
given if less than half (less than five) items were answered ‘yes’. Ratings of each of 
the included studies are shown in appendix 1.3.  
To ensure consistency in quality rating, a second independent rater also 
assessed all included papers. Each reviewer separately evaluated four papers then 
met to discuss individual ratings given. Agreement in overall quality was found for all 
four co-rated papers i.e. both gave the same overall quality rating for each paper (++, 
+ or 0). If disagreement arose around individual items and what scored ‘yes’, ‘no’ or 
‘can’t say’, this was resolved through discussion and ratings were revised to the 
agreed rating. The remaining four articles were then rated independently.  
 
Effect Sizes  
 Where feasible, effect sizes were calculated for differences between patients 
and controls on measures of DA within each study, irrespective of a statistically 
significant difference being found.  
 
Data Synthesis and Extraction  
 It is important to consider overall findings of included studies in the context of 
their methodological strengths and limitations. Due to variation in methodology and 
measures of DA between studies, a meta-analysis was not considered appropriate 
and a narrative synthesis was therefore undertaken [Popay et al., 2006].  
DClinPsy 2016 University of Glasgow 
 
 
15 
To systematically collect pertinent information from each included study, a 
data extraction form was developed (appendix 1.4). Using this tool, information 
regarding study characteristics, participant characteristics, recruitment, measures 
and results were extracted from each of the eight included papers.  
 
Results 
Study Characteristics  
 Eight studies met inclusion criteria for this review. Table 1 summarises the 
characteristics and quality ratings of included studies. Some studies also included 
participants with Primary or Secondary Progressive MS, but the review focused on 
results with RRMS.  
 Six of the eight included studies found significantly greater performance 
decrement in individuals with RRMS than with controls. One paper compared 
performance between groups on the DA measure, but no statistically significant 
difference was found. The other paper did not report a comparison between groups 
on DA task performance (despite including a control group) and therefore it could not 
be determined whether a DA deficit was present. Various DA measures were used 
across studies (see methodological limitations section below). Seven studies 
reported disease severity using the Expanded Disability Status Score (EDSS). Four 
reported EDSS scores as a range, which spanned from scores of 1.0 – 8.5. Three 
reported group mean EDSS scores of 1.4, 4.67 and 4.7. One study reported a mean 
Ambulatory Index (AI) score of 4.03.  
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Table 1: Summary of Included Studies with Sample Characteristics, Divided Attention Measures and Quality Ratings  
 
 
ID 
 
Study 
 
 
Sample Size and 
Characteristics 
 
Study Aim 
 
 
Measures  
of DA  
 
 
DA Deficit 
Reported in 
RRMS?  
 
 
Quality 
Score 
A Claros-
Salinas et 
al, 2013 
n MS = 32 
n Control = 20 
 
MS participants recruited from a 
neurological rehabilitation unit in 
Germany. Study does not state 
how control participants were 
recruited.   
 
Type of MS: RRMS, PPMS, 
SPMS  
 
EDSS: Average score of 3.6 
(range 1.0–6.5)  
 
To investigate 
whether 
cognitive fatigue 
in MS patients is 
a spontaneous 
phenomenon or 
if it can be 
provoked or 
exacerbated 
through 
cognitive effort 
and motor 
exercise.  
TAP-M: DA Subtest:  
Simultaneous Visual + Auditory tasks 
 
A visual task (white crosses appeared in a 
quasi random configuration – participants 
were asked to press a response key when 
detected target configuration) and an 
auditory task (200 pure tones presented 
successively one after the other – 
participants were asked to press a response 
key when detected a repetition of tone 
frequency) were performed simultaneously.  
 
Unknown 
(Control 
performance on 
TAP-M DA 
Subtest not 
commented on 
in results) 
+ 
B Devos et al, 
2013 
n MS = 15 
n Control = 17 
 
Participants in both groups were 
recruited through 
advertisements or after 
attending a local information 
session.  
 
Type of MS: RRMS, SPMS, 
PPMS 
 
EDSS: score range of 1–6 
(n7 = <3 & n8 = 3.5 – 6) 
To investigate 
whether driving 
performance is 
impaired in 
persons with 
mild to 
moderate MS.  
Two measures:  
1. Driving simulator (DS) with DA task  
 
2. Directions and Compass Tasks (DCT) (MS 
only) 
 
DS with DA: Driving scenario including daily 
traffic situations. Assessed driving skills such 
as adapting speed and avoiding hazardous 
situations. On top of these driving skills, DA 
symbols were randomly projected in the side 
mirrors. Participants responded e.g. by 
pressing the horn when seen a horn symbol.  
 
Yes 
(Significant 
difference 
between MS 
and controls on 
Driving 
Simulator DA 
task)   
++ 
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 DCT: Subjects were given a deck of cue 
cards depicting vehicles travelling in different 
directions. They were instructed to position 
these cards on a 4x4 matrix so that each 
vehicle was travelling in the directions 
indicated by either arrows or compass cards.  
 
C McCarthy 
et al, 2005 
n MS = 30 
n Control = 30 
 
Study does not state how MS or 
control participants were 
recruited.   
 
Type of MS: RRMS,  
CPMS  
 
EDSS: Range 1–8.5 
To consider the 
specific nature 
of attentional 
dysfunction in 
MS.  
DAT: Visual, Auditory and Bimodal Divided 
Attention Task (designed by authors)  
 
Participants were presented with pairs of 
digits and asked to respond when target pairs 
were presented. Digits were presented under 
visual, auditory and bimodal (visual + 
auditory) conditions.  
Yes 
(Controls group 
significantly 
more hits, fewer 
false positives, 
greater 
percentage of 
correct 
responses and 
faster response 
times than MS 
group)    
 
0 
D Patanella et 
al, 2010 
n MS = 30 
n Control = 30 
 
MS participants recruited from a 
MS Centre. Study does not state 
how control participants were 
recruited.   
 
Type of MS: RRMS  
 
EDSS: Mean 1.4 (SD of 1.2)  
To investigate 
the role of Brain 
Derived 
Neurotrophic 
Factor and 
inflammatory 
factors in the 
development of 
cognitive 
dysfunction in 
MS.  
 
Three Measures:  
1. MFTC 
2. SDMT 
3. TMA  
 
MFTC: A visual task in which subjects are 
requested to identify a target item in an array 
of distractors.  
 
SDMT: Using a reference key, participants 
have 90 seconds to pair specific numbers 
with given geometric figures.  
 
TMA: Circles are numbered 1-25 and 
participants should draw lines to connect the 
numbers in ascending order as quickly as 
can.  
Yes  
(Significant 
difference 
between MS 
and controls on 
MFCT reaction 
time, SDMT and 
TMA)    
 
+ 
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E Paul et al, 
1998 
n MS = 39 
n Control = 18 
 
MS participants recruited from 
the practices of neurologists and 
regional support groups in Tulsa 
and Oklahoma City. Control 
participants were recruited from 
the community e.g. patients 
relatives.   
 
Type of MS: RRMS, CPMS, 
SPMS  
 
AI: Mean score of 4.03  
 
To assess the 
status of 
attention in MS.   
Three Measures:  
1. Oral SDMT 
2. PASAT 
3. G-LAS 
 
Oral SDMT: Using a reference key, 
participants have 90 seconds to pair specific 
numbers with given geometric figures. 
Responses are given orally.  
 
PASAT: Single digits are presented every 3 
seconds and the participant must add each 
new digit to the one immediately prior to it.   
 
G-LAS: Requires participants to detect a 
target consisting of either a large global or 
smaller local forms hat as a whole constitute 
a global stimulus. Participants hit a response 
key when seen the target letters ‘S’ or ‘H’.  
 
Yes   
(Significant 
difference 
between groups 
on all DA 
measures)    
 
+ 
F Ruet et al, 
2013 
n PPMS = 41 
n RRMS = 60 
n Control = 415  
 
MS participants were recruited 
from the MS Centre of 
Bordeaux. Study does not state 
how control participants were 
recruited.   
 
Type of MS: PPMS,  
RRMS  
 
EDSS: 1.5 - 7.0 
(mean 3.5)  
 
 
To characterise 
the cognitive 
abilities of 
patients with 
PPMS and 
RRMS.   
 
To compare the 
cognitive 
patterns in 
PPMS and 
RRMS.  
TAP: DA Subtest:  
Simultaneous performance of visual and 
auditory tasks  
 
A visual task (white crosses appeared in a 
quasi random configuration – participants 
were asked to press a response key when 
detected target configuration) and an 
auditory task (200 pure tones presented 
successively one after the other – 
participants were asked to press a response 
key when detected a repetition of tone 
frequency) were performed simultaneously.  
 
No   
(No significant 
difference 
between RRMS 
and controls on 
TAP: DA 
Subtest) 
++ 
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G De 
Sonneville 
et al, 2002 
n MS = 53 
n Control = 58 
 
MS participants randomly 
selected at a secondary/tertiary 
referral centre for MS. Control 
participants recruited from the 
community.    
 
Type of MS: SPMS, PPMS, 
RRMS  
 
EDSS: Mean 4.7 (SD=2.0) 
[RRMS mean 3.0; SD=1.2] 
To evaluate 
information 
processing 
characteristics 
in patients with 
MS.  
ANTP: Visuo-spatial Processing (VSP) and 
Memory Search (MemS) subtests   
 
ANTP – VSP: After memorisation of a pre-
defined target pattern participants have to 
detect this target pattern in a signal 
consisting of four patterns. Press either ‘yes’-
key or ‘no’-key.  
 
ANTP – MemS: Employs a display load of 
four letters and consists of three parts in 
which target set size (memory load) is 
increased from one to three target letters. 
Press either ‘yes’-key or ‘no’-key.  
   
Yes 
(Significant 
differences 
found between 
groups on both 
DA measure for 
speed of 
processing only 
– not for 
accuracy)  
 
0 
H Stoquart-
ElSankari 
et al, 2010 
n MS = 20 
n Control = 20 
 
MS participants were admitted in 
the Department of Neurology of 
Amiens University Hospital. 
Study does not state how control 
participants were recruited.   
 
Type of MS: SPMS, PPMS, 
RRMS   
 
EDSS: Mean 4.67  
 
To examine 
mechanisms 
accounting for 
action slowing in 
MS patients.  
SRT task (dual-task condition aimed to 
assess DA)  
 
Imperative stimuli were letters randomly 
chosen among four letters. They appeared 
with a randomly varying interval (100, 150, 
200, 250 and 300 ms) after the extinction of a 
warning visual stimulus (fixation cross). 
Subjects had to depress as fast as possible 
the response key with their index finger, 
regardless of the letter.   
Yes  
(Significant 
differences 
found between 
groups on SRT 
task for reaction 
time – not for 
omissions) 
 
+ 
Note: Quality Rating Scoring: ++ = High quality; + = Acceptable; 0 = Low quality.  Abbreviations: DA = divided attention; MS = Multiple 
Sclerosis; RRMS = Relapsing-Remitting MS; SPMS = Secondary Progressive MS; PPMS = Primary Progressive MS; CPMS = Chronic 
Progressive MS; EDSS = Expanded Disability Status Score; SD = Standard Deviation; TAP-M = Test of Attentional Performance (mobile 
version); TAP = Test of Attentional Performance; PASAT = Paced Auditory Serial Addition Test; SDMT = Symbol Digit Modalities Test; DAT 
= Divided Attention Task; MFTC = Multiple Features Target Cancellation Test; TMA = Trail Making Part A; AI = Ambulatory Index; G-LAS = 
Global-Local Attention Shift; ANTP = Amsterdam Neuropsychological Tasks Program; SRT = Simple Reaction Time.   
DClinPsy 2016 University of Glasgow 
 
 
20 
Quality Ratings  
 Overall quality ratings ranged from low quality (0) to high quality (++) with a 
median rating of acceptable (+). A summary of quality scores for each study can be 
found in appendix 1.3. All eight studies had a clear aim or purpose, ensured cases 
and controls were taken from comparable populations, confirmed cases were clearly 
defined and differentiated from controls, and reported disease severity using a 
standardised measure which ensured that exposure status was measured in a valid 
and reliable way. The two studies with the lowest overall quality ratings tended not to 
have reported exclusion criteria for controls; did not compare participants and non-
participants; did not clearly establish that controls were non-cases; did not provide 
validity and reliability information for measures used; did not control for key 
confounders; and did not report confidence intervals.  
Studies were considered to have identified the main potential confounders if 
they included measures of, and controlled for, the following six key variables in their 
design or analysis: age, gender, IQ or education, depression, anxiety and fatigue. It 
is important to control for such confounders as they may explain why some of the 
dual-tasking difficulties found are common in MS. Only two studies controlled for all 
six variables. All studies controlled for age and gender. Six also controlled for 
education or IQ level. One study did not include any measures to control for 
depression, anxiety or fatigue variables. Seven studies controlled for one of these 
three variables. More specifically, six of the seven studies included a measure of 
depression, six included a measure of fatigue, and three included a measure of 
anxiety. Only three studies included measures of all three of these potential 
confounding variables. Two additional confounders were important to consider for 
one paper that used a driving simulator: visual acuity and motor ability. This paper 
controlled for seven potential confounders (excluding level of education).  
Overall, it was difficult to ascertain whether study quality influenced findings, 
due to differences in measures used to assess DA, discrepancy between the key 
potential confounders controlled for and methodological limitations (outlined below). 
For example, although all eight studies utilised neuropsychology tests to assess DA, 
the measures used varied and in one particular study [Devos et al., 2013] one of the 
two DA measures was only used in the MS group. This meant performance on that 
measure could not be compared with control subjects.  
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Effect Sizes  
Effect sizes could not be calculated for one paper, but were calculated for 
each measure of DA for the seven remaining studies. Two of the seven studies had 
reported effect sizes. For the five studies that did not report effect sizes, Cohen’s d or 
r was calculated for differences between groups on all measures of DA. One of the 
five studies reported median and interquartile-ranges (IQR) [Devos et al., 2013], and 
therefore an estimated mean and variance (standard deviation) was calculated using 
the formulas (below) [Hozo, Djulbegovic, & Hozo, 2005]; Cohen’s d was then 
calculated using the estimated figures. For both formulas: median (m); low end of 
IQR (a); and high end of IQR (b).  
 
Formula 1: Calculating estimated mean  Formula 2: Calculating estimated 
variance  
 
Table 2 summarises effect sizes for all DA measures used where effect size 
calculations were possible. An overall weighted effect size was not calculated given 
the heterogeneity of the measures used. Calculated individual effect sizes ranged 
from 0.00 to 5.77 across studies, with a median individual effect size of 0.69, which is 
in the medium–large effect size range [Cohen., 1988]. 
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        Table 2: Summary of Individual Effect Sizes for Divided Attention Tasks in Studies 
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Methodological Limitations of Reviewed Studies  
Several methodological limitations were identified. Firstly, there was 
considerable variability in the tests used to measure DA (see table 1).  
Five of the eight studies used a single measure of DA. Of these five studies, 
one study used the Test of Attentional Performance (TAP), a test used to examine 
different aspects of attention. Another study used the mobility version of the TAP test 
namely TAP-M, which was developed to test aspects of attention in driving abilities 
[Zimmerman & Fimm, 2005]. The third study used the Divided Attention Task (DAT), 
which uses visual, auditory and bimodal tasks. The fourth study used the ‘Visuo-
spatial Processing’ and ‘Memory Search’ subtests of the Amsterdam 
Neuropsychological Tasks Program (ANTP). Finally, the fifth used a Simple Reaction 
Time (SRT) task under single and dual-task conditions. The three remaining studies 
used multiple measures of DA in their studies. One used a Driving Simulator with DA 
task and the Directions and Compass Tasks. Another used the Multiple Features 
Target Cancellation Test (MFTC), the Symbol Digit Modalities Test (SDMT) and the 
Trail Making Test – Part A (TMA). The final study used the oral version of the SDMT, 
the Paced Auditory Serial Addition Test (PASAT); and the Global-Local Attention 
Shift (G-LAS) test.  
A critical issue was whether the tests used actually measured DA. Dual-
tasking paradigms have been utilised to study DA and the fundamental properties of 
the central executive system in several populations [Baddeley, Bella Sala, Gray, 
Papagno, & Spinnler, 1997]. A measure was deemed to have successfully measured 
DA if it adhered to a dual-task paradigm, which requires participants to perform two 
different tasks individually and then simultaneously, with DA being examined in 
relation to the dual-task cost (i.e. level of decrement in performance from single to 
dual-task conditions). Two of the eight studies included a measure of DA that met 
this criteria and statistically examined interactions of single and dual-task 
performance between MS and control groups [McCarthy et al., 2005; Stoquart-
ElSankari et al., 2010]. These studies used the following tests: DAT and SRT Task. 
Both studies found a significant dual-task cost in the MS group compared to controls. 
However, only one paper assessed DA performance by type of MS (RRMS and 
PPMS) as opposed to MS group as a whole [Stoquart-ElSankari et al., 2010]. This 
paper found a significant decrement in performance from single to dual-task in both 
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forms of MS compared to controls, with PPMS individuals performing worse than 
RRMS.  
The remaining six studies used a range of other test formats. One study used 
the TAP-M test and stated that their participants completed visual and auditory tasks 
simultaneously, however, did not state whether the two tasks also had to be 
performed under single task conditions. Another study that used a driving simulator 
with a DA task did not ask participants to complete tasks individually, only 
simultaneously. A further study used the TAP test and although tasks were 
completed individually then simultaneously, DA decrement was not examined in 
relation to the dual-task cost. The remaining three studies used the following tests: 
MFTC, SDMT, TMA, PASAT, G-LAS and ANTP. None of these tests meet dual-task 
paradigm criteria, as they do not require individuals to attend to two tasks or streams 
of information simultaneously. The SDMT and TMA tests ask individuals to attend to 
one task and complete it as quickly and accurately as they can. The MFTC, PASAT, 
G-LAS and ANTP tests require persons to attend to one task and select target items 
amongst distractor items.   
A third factor was the lack of control for potential confounding variables. 
Studies were considered to have identified the main potential confounders if they 
controlled for six key variables in their design or analysis (see above quality rating 
section). Six of the eight included studies did not control for all aforementioned 
potential confounding variables. This made it difficult to determine if relationships 
found between independent and dependent variables in these studies were 
confounded by other variables.  
A final methodological limitation was a lack of statistical exploration of disease 
severity range and performance on DA tasks. The most routinely used tool to 
measure MS disease progression in research trials is the Expanded Disability Status 
Score (EDSS) [Goldman, Motl, & Rudick, 2010], which is a 10-point scale. A score of 
0–3.5 indicates that MS disease progression is in the low range and is based on 
changes in one or more functional system e.g. ambulation. A score of 4.0–6.0 is in 
the moderate range and is based on gait dysfunction. Scores of 6.0–7.5 is the 
moderate–severe range and is based on walking function. Scores over 7.5 are in the 
severe range and are based on loss of ambulation (score 8.0), loss of upper 
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extremity function (score 8.0–9.0), loss of bulbar function (score 9.0–9.5) and finally 
death (score 10) [Goldman et al., 2010]. 
Seven of the eight included studies reported EDSS scores. Six of the seven 
used Kurtzke’s (1983) version of EDSS and one used a French adapted version of 
this tool. EDSS scores were reported as range, mean or both. The remaining study 
used the Ambulatory Index (AI) to measure disease progression. The AI is a 9-point 
scale which measures overall physical disability. A score of zero indicates no 
physical disability whilst a score of nine indicates wheelchair-dependency [Paul et al., 
1998]. 
To establish if a DA deficit is present early in the MS disease course, it is 
important to determine whether DA deficits are present in individuals with low-range 
EDSS scores. Two studies [Claros-Salinas et al., 2013; Devos et al., 2013] reported 
EDSS but did not explore DA task performance in terms of disease severity range. 
Both studies had EDSS scores ranging from 1.0–6.0 (low–moderate severity). One 
found a DA deficit in the MS group as a whole compared to controls whilst the other 
did not report necessary data to determine if a DA deficit existed. One of the six 
remaining studies included solely RRMS participants [Patanella et al., 2010], had a 
mean EDSS of 1.4 (low range) and found a significant difference between RRMS and 
controls on reaction time but not accuracy for the DA tasks used.  
Five studies reported EDSS scores for the different forms of MS, which further 
allowed for consideration of the relationship between EDSS severity range and DA 
task performance. One of the five studies [McCarthy et al., 2005] had an EDSS score 
range of 1.0–8.5 but found no significant differences in EDSS scores between MS 
subtypes (RRMS and CPMS). However, this study did find a DA deficit in the MS 
group as a whole compared to controls. Conversely, the remaining four studies found 
a significant difference in EDSS/AI scores between MS subtypes. In all four studies, 
RRMS participants scored within the low disease progression range whilst other 
forms of MS (PPMS; SPMS) scored 3.5–6.1 across studies (moderate range). One of 
the four studies did not differentiate between MS subtype and DA task performance 
but did find a DA deficit in the MS group as a whole compared to controls [Paul et al., 
1998]. The remaining three studies explored DA task performance between the 
control group and both the entire MS group and MS subtypes. Two studies found a 
significant difference in DA performance between the MS and control groups and 
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also between RRMS and PPMS subgroups and the controls. Both studies also found 
that progressive subtypes performed worse than RRMS participants. The final study 
found no significant differences on DA task performance between either MS subtype, 
RRMS and PPMS, and their matched controls.  
The differing approaches to exploration of the relationship between disease 
severity and performance on DA tasks made it difficult to ascertain if the DA deficits 
reported were seen early in disease course or not. More specifically, when entire MS 
groups were compared to controls, if a DA deficit was found, it was difficult to 
determine what range(s) of disease severity contributed to this. For example, it could 
be that those with higher EDSS scores are strongly influencing DA scores. Three 
studies examined DA task performance in the MS subtypes and compared them to 
controls. In these studies participants with RRMS had an EDSS in the low range. 
Two of the three studies found a DA deficit in the RRMS group; one did not. Two of 
these three studies controlled for all confounding variables (outlined above), one 
found a deficit [Stoquart-ElSankari et al., 2010] and one did not [Ruet et al., 2013]. 
This discrepancy in results could be due to different tests of DA being used.  
 
Discussion 
This review asked three questions: (1) is there a DA deficit in RRMS; (2) what 
methods are used to measure DA in RRMS; and (3) if there is a DA deficit, does this 
seem to be evident early in the disease course? Firstly, six of the eight included 
studies found a DA deficit in the RRMS group in comparison to control subjects. 
Secondly, various methods were used to measure DA; this was a methodological 
limitation. Lastly, due to a lack of statistical exploration of the relationship between 
level of disease severity and performance on DA tasks, it was difficult to ascertain if 
the DA deficits found were seen early in disease course or not.  
Two of the eight included papers did not find a DA deficit in RRMS 
participants. One paper did not report a comparison between groups on DA task 
performance and therefore it could not be determined whether a DA deficit was 
present, despite including a control group in their study and reporting comparisons on 
other cognitive domains [Claros-Salinas et al., 2013]. The other paper compared 
performance between groups on the DA measure but no statistically significant 
difference was found [Ruet et al., 2013]. The latter paper reported ratio scores for the 
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DA task used (TAP: DA Subtest) which gave a form of decrement score. Results 
suggested that for most patients and controls no decrement was found. For example, 
controls had a ratio score of 1.0 on several measures with a standard deviation of 0.0 
indicating no variation in scores at all. This means that the distributions were not 
normally distributed and therefore the use of parametric t-tests was inappropriate. 
This may partly explain why a DA deficit was not found in this paper.  
Several methodological limitations were identified in the eight included studies, 
which made it difficult to answer the three review questions. When considering the 
concept of DA and how best to measure this ability, it is important to consider 
cognitive models of attention. Arguably, the most frequently referenced theory of 
attention is Baddeley’s (1986) working memory model [Baddeley et al., 1997]. This 
multi-structure model proposes that a central executive regulates and allocates 
limited attentional resources to two slave systems: phonological loop and visuospatial 
sketchpad. A pivotal role of the central executive system is to efficiently apportion 
and manage attentional resources when two or more tasks are being performed 
simultaneously or when attention is divided between the two slave systems. Dual-
tasking or DA paradigms have been utilised considerably to study the fundamental 
properties of the central executive system in several patient populations [Baddeley et 
al., 1997]. Of the eight included studies, only two adhered to a dual-task paradigm 
when measuring DA.  
The two studies that adhered to a dual-task paradigm used the following tests: 
DAT and SRT Task. The six remaining studies utilised a variety of different tests with 
dissimilar designs. For example, the PASAT asks participants to listen to digits 
presented at either 2 or 3-second intervals and add each new digit to the number 
presented immediately beforehand. In contrast, the SDMT requires participants to 
quickly and accurately pair numbers and figures using an index key. Whether these 
tests truly measure DA is questionable. The designs of such tests arguably involve 
different cognitive abilities such as sustained attention, working memory and 
processing speed as opposed to DA. The PASAT and SDMT have commonly been 
used and have been proven to be sensitive to information processing speed and 
working memory deficits in individuals with MS [Skelly, Dettori, & Brodt, 2012; Wood 
et al., 2012]. However, it is debateable whether these tests satisfy Baddeley and 
colleagues suggested methodological criteria for comprehensively measuring DA. 
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Given the varying methodologies of the included measures of DA used across the 
eight studies, and that a significant number did not adhere to a dual-task paradigm, 
the DA deficits reported are called into question.  
Another factor that made it difficult to determine if a true DA deficit existed was 
the lack of control for potential confounding variables. This potentially leads to flawed 
conclusions regarding the association between independent and dependent variables 
[Wood et al., 2012]. Controlling for all potential confounding variables ensures that if 
a relationship between the independent and dependent variables are found, this is a 
true association [Skelly et al., 2012]. Looking solely at the two studies that controlled 
for all six potential confounding variables (age, gender, education/IQ, anxiety, 
depression, fatigue) [Ruet et al., 2013; Stoquart-ElSankari et al., 2010], although both 
studies controlled for confounders and included measures of DA that adhered to a 
dual-task paradigm, only one found a deficit in DA when comparing RRMS 
performance with controls [Stoquart-ElSankari et al., 2010]. Overall, it is unclear if 
mood or fatigue levels have contributed to the reported DA deficits seen in the MS 
groups and therefore whether a true DA deficit exists in RRMS.  
With regard to confounders, whilst one might want to control for these 
variables to understand whether there is a direct link between MS pathology and DA 
deficits, it is still important to know whether there is an uncontrolled difference 
between groups because it may be that a ‘confounder’ is actually a moderator, or 
even a mediator of the effect. For example, it may be that anxiety is a mediator such 
that anxiety depletes attentional resources making dual-tasking more difficult and that 
people with MS are more likely to be anxious than healthy controls. Thus controlling 
for anxiety would potentially remove the difference between people with MS and 
controls, but that does not mean that people with MS do not have a DA deficit.   
The final factor that made it difficult to answer the third review question was a 
lack of statistical exploration of disease severity range and performance on DA tasks. 
It is important to consider if DA difficulties occur early in MS so that interventions, 
which may ameliorate deficits in attention, can be introduced in a timely manner. If 
we know deficits in DA are relatively common in these earlier stages clinicians will be 
in a better position to inform patients to try to be aware of them and seek help in 
managing them. As MS progresses, the more wide ranging cognitive difficulties may 
be present including DA problems but it is less certain that such difficulties are 
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present earlier in the disease course. Although all studies incorporated a 
standardised measure of disease progression (EDSS or AI), there was a lack of 
consideration given to level of disease severity and cognitive performance. However, 
in three studies participants with RRMS had an EDSS in the low severity range. Two 
of the three studies found a DA deficit in the RRMS group; one did not. Two of these 
three studies controlled for all confounding variables, one found a deficit [Stoquart-
ElSankari et al., 2010] and one did not [Ruet et al., 2013]. This discrepancy in results 
could be due to different tests of DA being used. Overall, it remains unclear whether 
a DA deficit exists early in MS disease progression.  
 
Future Research  
 None of the included studies aimed to solely assess DA in MS. Future 
research should be conducted to answer this specific question in order to clearly 
ascertain whether decrement found under dual-task conditions is a result of a central 
problem with DA or if it is a resource limitation issue. Below are recommendations for 
future researchers to consider when designing a study.  
 
Recommendations 
1. Methodology should include a justification of sample size based on power 
calculations.  
2. Study design should incorporate clear inclusion and exclusion criteria for both 
case and control subjects.  
3. All potential confounders should be taken into consideration at the study 
design level. Principally: age, gender, education or IQ level, mood and fatigue. 
Matching case and control subjects by age, gender and education/IQ level will 
control for these potential confounders. It is also important to explore the 
possible contribution of mood and fatigue levels on performance of DA 
measures using valid and reliable measures.  
4. Careful consideration should be given to test selection to ensure DA is 
accurately measured. Incorporating tests that adhere to Baddeley and 
colleagues’ dual-task paradigm.  
5. Study design should incorporate a standardised tool of disease severity such 
as EDSS to measure disease progression and severity.  
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Conclusion 
It was not possible to definitively conclude that a DA deficit is evident in 
individuals with RRMS. This was due to the varying methodologies employed and 
varying measures of DA used, a lack of adherence to a dual-task paradigm, and 
limited control for potential confounding variables across the eight included studies. 
Two of the eight studies used a measure of DA that met dual-task paradigm criteria 
and statistically examined interactions of single and dual-task performance between 
MS and control groups. Both studies found a significant dual-task cost in the MS 
group compared to controls. However, one study had a ‘low quality’ rating and did not 
assess DA performance by type of MS i.e. RRMS. The remaining study used a 
measure of DA that met dual-task paradigm criteria, controlled for all confounding 
variables, and had ‘acceptable’ quality rating. This study found that RRMS 
participants performed significantly more poorly than controls on the DA task (SRT 
Task). This suggests that a DA deficit may exist in RRMS and warrants further 
investigation. Future studies should address outlined methodological issues.  
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Plain English Summary 
Background: Impairments in memory and thinking abilities (cognition) and problems 
with balance are common in Multiple Sclerosis (MS). Such difficulties can impact on 
a person’s ability to take part in meaningful everyday activities, maintain a job and 
are associated with reduced quality of life. Although evidence shows there are 
shortfalls in memory and thinking abilities and balance performance in MS, few 
studies have examined the link between these factors in people with MS. A small 
number of studies that use ‘dual-task designs’, where people are asked to perform a 
cognitive task by itself, a balance task by itself, and to do the cognitive and balance 
tasks at the same time, have found that people with MS have difficulty doing the two 
tasks at the same time. In contract, other studies have found people with MS can 
perform the two tasks together with little difficulty. Objective: To investigate: (1) 
Whether individuals with MS have more difficulty performing balance and cognitive 
tasks at the same time compared to healthy control subjects; (2) If there is a 
connection between how people perform when doing two tasks at the same time and 
scores on a questionnaire that ask how able people are doing two things at the same 
time in everyday life. In addition, levels of anxiety and depression, tiredness and 
severity of MS were examined to see if they impacted a person’s ability to do a 
cognitive and a balance task at the same time. Methods: Thirty-four participants with 
Relapsing Remitting MS (RRMS) and thirty-four healthy controls took part. 
Participants completed cognitive and balance tasks separately and at the same time. 
The cognitive task required participants to listen to pre-recorded numbers and repeat 
them back in reverse order to how they heard them (e.g. heard 5-2-4; answer 4-2-5). 
The balance task required participants to stand barefoot on a metal or foam surface 
and hold their balance as best they could. When doing the two tasks at the same 
time, participants had to listen to the numbers and repeat them back in reverse order 
at the same time as holding their balance as best they could. Results: Participants 
with RRMS had more difficulty doing the balance and cognitive tasks at the same 
time compared to controls. Tiredness and severity of MS did not impact a person’s 
ability to do the two tasks at the same time. However, it appears that when a person 
with RRMS is more anxious or depressed this influences their ability to perform the 
two tasks at the same time. Conclusions: RRMS causes difficulties doing a 
cognitive and a balance task at the same time, impacting particularly on ability to 
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maintain balance. This may contribute to an increased risk of walking difficulties and 
falls. The striking relationship between anxiety/depression and dual-task performance 
suggests that worry may be contributing to difficulties doing two tasks at the same 
time. This raises the possibility that Psychological interventions aimed at managing 
worry may improve a person’s ability to do a cognitive and a balance task at the 
same time.   
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Abstract 
Background: People with relapsing remitting MS (PwRRMS) suffer disproportionate 
decrements in gait under dual-task conditions, when walking and a cognitive task are 
combined. There has been much less investigation of the impact of cognitive 
demands on balance. This study investigated whether: (1) PwRRMS show 
disproportionate decrements in postural stability under dual-task conditions 
compared to healthy controls; (2) dual-task decrements are associated with everyday 
dual-tasking difficulties. In addition, the impact of mood, fatigue and disease severity 
on dual-tasking were also examined. Methods: 34 PwRRMS and 34 matched 
controls completed cognitive (digit span) and balance (movement of centre of 
pressure on a Biosway, on stable and unstable surfaces) tasks under single and 
dual-task conditions. Everyday dual-tasking was measured using the DTQ. Mood 
was measured by the HADS. Fatigue was measured via the MFIS. Results: No 
differences in age, gender, years of education, estimated pre-morbid IQ or baseline 
digit span between the groups. Compared to healthy controls, PwRRMS showed a 
significantly greater decrement in postural stability under dual-task conditions on an 
unstable surface (p=0.007), but not a stable surface (p=0.679). PwRRMS reported 
higher levels of everyday dual-tasking difficulties (p<0.001). Balance decrement 
scores were not correlated with everyday dual-tasking difficulties, or with fatigue. 
Stable surface balance decrement scores were significantly associated with levels of 
anxiety (rho=0.527, p=0.001) and depression (rho=0.451, p=0.007). Conclusion: 
RRMS causes difficulties with dual-tasking, impacting balance, particularly under 
challenging conditions, which may contribute to an increased risk of gait difficulties 
and falls. The striking relationship between anxiety/depression and dual-task 
decrement suggests that worry may be contributing to dual-task difficulties.  
 
Key words: Adult, attention, memory, neuropsychological tests, postural stability, 
balance, multiple sclerosis, nervous system disorders  
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Introduction 
Cognitive impairment is common in Multiple Sclerosis (MS), occurs at all 
disease stages and can be a primary source of social dysfunction, occupational 
disability and diminished quality of life [Rodgers & Panegyres, 2007]. Estimated 
prevalence of cognitive impairment in people with MS (PwMS) ranges between 43% 
and 65% [Denney, Sworowski, & Lynch, 2005] typically involving difficulty with 
attention, memory, information processing speed and executive functions [Goretti et 
al., 2014; Whelan et al., 2010].  
Balance and gait difficulties and associated risk of falling in PwMS are well 
documented [Cattaneo et al., 2002; Leone, Patti, & Feys, 2015]. Where balance or 
gait is impaired, greater attention allocation may be required to maintain effective 
stability. Postural control has been defined as, “the control of the body’s position in 
space for the purposes of balance and orientation” [Shumway-Cook & Woolacott, 
2000]. Conventionally it has been considered a reflex or automatic controlled task, 
with the implication that minimal attentional resource is used by postural control 
systems [Woolacott & Shumway-Cook, 2002]. Recent research contradicts this 
hypothesis, suggesting there are substantial attentional requirements for postural 
control [Donker, Roerdink, Greven, & Beek, 2007; Yogev-Seligmann et al., 2008].  
Dual-task designs, where participants perform cognitive and motor tasks 
concurrently, have been used to investigate the possible interaction of cognitive 
functioning and posture [Andersson, Hagman, Talianzadeh, Svedberg, & Larsen, 
2002]. Boes and associates (2012) investigated the effects of dual-tasking on 
postural control in PwMS with mild or moderate disability. Participants undertook 
posturography testing under a single-task and cognitive dual-task condition. Results 
showed that postural control was compromised by dual-task demands and declined 
with disability status. Moreover, a small number of studies further suggest that PwMS 
display a significant decrement in balance or gait under dual-task conditions when 
compared to control subjects [Hamilton et al., 2009; Cameron & Lord, 2010; Kalron, 
Dvir, & Achiron, 2010; Jacobs & Kasser, 2012]. Additionally, some research 
concludes that poor postural control contributes to increased risk of falling for PwMS 
[Cattaneo et al., 2002; Cameron & Lord, 2010]. However, other studies indicate no 
decrement in gait and cognition under dual-task conditions [Andersson et al., 2002; 
Allali, Laidet, Assal, Armand, & Lalive, 2014]. Varying results within the evidence-
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base warrant further investigation of balance and gait decrement in PwMS, 
particularly focused on understanding the impact of dual-tasking on cognitive 
functioning [Wajda, Motl, & Sosnoff, 2014] and to explore further possible causal 
factors of dual-task deficits [Leone et al., 2015].  
There have been relatively few attempts to explain the presence of dual-tasking 
decrements. One possibility is that there is a central problem with divided attention so 
that tasks cannot be combined. Another is that damage to motor systems leads to 
greater demand for conscious attention while performing motor tasks, and as a 
result, insufficient attentional resource is available for secondary tasks [Kalron et al., 
2010]. A further alternative is that in certain neurological disorders working memory 
capacity is reduced. This results in more attentional resource being required when 
performing previously low attentionally demanding cognitive and motor tasks. This 
increase in attentional demand causes the attentional system to be overloaded, 
resulting in reduced cognitive capacity [Kalron et al., 2010] and poor balance/gait 
[Leone et al., 2015]. The evidence so far does not conclusively point to one or other 
of these possible explanations. 
In summary, emerging evidence suggests that deficits in attention and 
balance/gait are present in MS. However, there is paucity in evidence regarding the 
interaction of demands on these systems in PwMS. If it is true that for some PwMS, 
balance/gait difficulties are either only apparent or disproportionally impaired under 
dual-task conditions, then it may be prudent to measure this routinely in clinical 
practice. The twofold aim of this study is to investigate: (1) if people with Relapsing 
Remitting MS (PwRRMS) have increased difficulties with balance and cognitive-
motor dual-tasking compared to control subjects; (2) if there is a relationship between 
dual-task performance and everyday functioning measured by scores on a self-report 
questionnaire, the Dual-Task Questionnaire (DTQ) [Evans, Greenfield, Wilson, & 
Bateman, 2009]. In addition, the impact of mood, fatigue and disease severity 
(EDSS) on dual-tasking will also be examined. Estimated prevalence rates for 
depression range from 10% to 41.8%; anxiety 23.5% to 41%; and fatigue 60% to 
92% [Wood et al., 2012]. In order to determine whether dual-task decrements, if 
present, are caused by MS disease pathology it is important to consider the impact of 
potential confounders such as mood, fatigue and level of disease severity.   
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Hypotheses 
1. Compared to healthy controls, PwRRMS will show greater decrement under 
dual-task conditions compared to single-task conditions on measures of 
balance, digit span, and a combined decrement score.  
2. There will be a significant correlation between measures of dual-task 
decrement and scores on the DTQ.   
 
Methods 
Ethical Approval 
 Ethical approval was obtained from NRES Committee East Midlands – 
Nottingham 2 (Appendices 2.2 and 2.3). NHS Highland Research and Development 
Department granted management approval (Appendix 2.4). Participation in the study 
was voluntary and all participants provided written informed consent.  
 
Justification of Sample Size 
Few studies have examined dual-tasking with postural measures as 
outcomes. Kalron et al (2011) considered the effect of a cognitive task on postural 
control in individuals with a clinically isolated syndrome suggestive of MS and control 
subjects [Kalron, Dvir, & Achrion, 2011]. They found that controls showed greater 
decrement from single to dual-task conditions than PwMS, but the very mild sample 
was unrepresentative of PwMS. Jacobs and Kasser (2012) reported that PwMS 
showed significantly greater decrement compared to controls on a postural task but 
provided insufficient data to calculate an effect size. Wajda, Motl and Sosnoff (2014) 
investigated the demographic, cognitive and clinical correlates of dual-task-cost of 
balance in PwMS but had no control group.  
In their study of gait under dual-task conditions, Hamilton et al (2009) found 
medium-large effect sizes for a number of dual-task decrement measures (ranging 
from d=0.7 to d=1.5). In the present study we took a number of approaches to try to 
maximise effect sizes, such as inclusion of a wider range of disability levels of MS 
participants and use of a backward digit span task which is more challenging than the 
previously used forward digit span tasks. However, given that the nature of the motor 
task is different from that used by Hamilton et al, we took a conservative approach 
and powered the study on the basis of the lower of the effect sizes (d=0.7). Using 
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G*Power 3.1 [Faul, Erdfelder, Buchner, & Lang, 2009], with power set at 0.8, alpha at 
0.05 (two-tailed), d=0.7, a minimum of 34 participants per group was required.  
 
Participants 
Thirty-five RRMS participants were recruited through NHS Highland 
Neuropsychology, Neurology, MS Nurses and MS Therapy Centre services. Inclusion 
criteria for RRMS participants were: (i) diagnosis of RRMS; (ii) aged between 17-65 
years; (iii) free of relapse 30 days prior to task administration; (iv) an Expanded 
Disability Status Scale (EDSS) Score of up to 6.5 [Multiple Sclerosis Trust., 2013] (v) 
capacity to consent. A Consultant Neurologist sub-specialising in MS confirmed 
diagnosis and EDSS Score based on standardised investigation and in alignment 
with the revised McDonald diagnostic criteria [Polman et al., 2010]. Thirty-four control 
participants included a convenience sample of family of the MS participants and 
volunteers recruited through poster advertisement in local hospitals. Volunteers were 
accepted as control participants if they matched an RRMS participant by age and 
gender. Exclusion criteria for all participants were: (i) presence of major psychiatric 
disorders; (ii) history of neurodegenerative disease (other than MS) or brain injury; 
(iii) significant sensory deficits e.g. visual impairment; and (iv) severe co-morbid 
health condition affecting motor abilities e.g. diabetes; (v) inability to stand (for 
whatever reason).  
 
Design 
A between-subjects design was used to compare balance and dual-tasking 
performance amongst RRMS and control participants under single and dual-task 
conditions. A within-subjects design was used to examine the association between 
self-reported scores on mood and the divided attention questionnaire and dual-
tasking performance.  
 
Measures 
Demographic information was collected from all participants (gender, age, 
education) and in addition for RRMS participants, disease onset, years of illness and 
EDSS score.  
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Baseline Assessment  
Hospital Anxiety and Depression Scale (HADS) [Zigmond & Snaith., 1983] (all 
participants)  
Anxiety and depression were screened using the HADS. This self-report 
measure was designed for use with non-psychiatric hospital patients. The HADS 
reliability and validity has been described as being good to very good with internal 
consistency coefficients of 0.8, concurrent validity of 0.6–0.8 and both specificity and 
sensitivity of 0.8 [Bjelland, Dahl, Haug, & Neckelmann, 2002]. An exclusion criterion 
of this study was the presence of major psychiatric disorders. The authors of the 
HADS recommend that, for depression and anxiety scales alike, raw scores of 8-10 
identify mild cases, 11-15 moderate, and 16+ severe [Zigmond & Snaith, 1983]. 
Therefore, if participants scored 16+ on either the anxiety or depression items of the 
HADS they would be excluded from the study.  
 
Modified Fatigue Impact Scale (MFIS) [MSCCP., 1998] (all participants)  
This 20-item self-report measure was used to assess fatigue. It is a 
recommended measure of fatigue in MS [MSCCP., 1998] with good reliability and 
validity. It has an intra-class correlation coefficient of 0.91, internal consistency 
coefficient of 0.92 and a convergent validity coefficient of 0.67 [Kos et al., 2005].  
 
Multiple Sclerosis Impact Scale (MSIS-29) [Hobart, Lamping, Fitzpatrick, Riazi, 
& Thompson, 2001] (RRMS participants only) 
This 29-item self-report measure was used to assess quality of life in 
PwRRMS. It has been shown to have good variability, small floor and ceiling effects, 
high intra-class correlation coefficient of 0.87, and high internal consistency 
coefficients of 0.91 [Hobart et al., 2001].  
 
Dual-Task Questionnaire (DTQ) [Evans et al., 2009] (all participants) 
The 10-item DTQ was used to measure self-reported ability to divided 
attention. This questionnaire asks PwMS to rate how often they experience certain 
dual-task difficulties in day-to-day life. For example, “do you need to stop an activity 
to talk?” There are 5 response options ranging from very often to never, or not 
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applicable. Evans et al. reported a test-retest correlation of 0.690 (p<0.04) [Evans et 
al., 2009].  
 
Test of Premorbid Function (TOPF) [Wechsler., 2011] (all participants) 
Premorbid intellectual functioning was assessed using the TOPF. It has been 
shown to have a high level of internal reliability (0.95) and high test-retest stability 
(correlations ranging from 0.89 to 0.95) [Pearson Education Ltd, 2010].  
   
Addenbrooke’s Cognitive Examination (ACE-III) [Hsieh, Schubert, Hoon, 
Mioshi, & Hodges, 2013] (all participants) 
The ACE-III, a short cognitive test designed to screen for dementia, was 
utilised to assess general cognition. It has not been validated specifically with an MS 
population but has been used in one prior MS study [Hamilton et al., 2009] to 
describe basic cognitive functioning of MS and control subjects. Sensitivity is 
reported to be 0.94 and specificity 0.89 for the optimal cut-off in relation to 
distinguishing people with dementia from controls. This is with a cut-off score of 
88/100 [Hodges., 2007].  
 
Cortical Vision Screening Test (CORVIST) [James, Plant, & Warrington, 2001] 
(all participants)  
This 10-subtest measure was used to assess visuoperceptual ability. Each 
subtest measures a different aspect of visual processing and identifies cortical based 
visual problems. The CORVIST was used to ensure participants did not have 
significant visual impairment.  
 
Backwards Digit Span [Cocchini et al., 2004] (all participants)  
Individual digit span assessments were completed based on a method 
developed by Cocchini et al (2004) (see appendices 2.10–2.13). At baseline, digit 
span was established for each individual. Participants heard digit lists at a rate of one 
per second and were asked to repeat these back in reverse order (e.g. heard: 5-2-4; 
answer: 4-2-5). Initial span length was two digits and participants were presented 
with six sequences at each span length. If five out of six digits were accurately 
recalled, the digit sequence was lengthened by one digit. Individual digit span was 
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determined as the last sequence length at which five out of six responses were 
correct. Established individual span length was then used during single and dual-task 
conditions.   
 
Balance Tasks  
BioSway [Biodex., 2015] (all participants)  
Postural stability was measured using the BioSway, which is a flexible balance 
assessment device. It measures neuromuscular control and capability to balance on 
firm and unstable surfaces. It has good reliability with an intra-class correlation 
coefficient of 0.81 [Biodex., 2015]. The dimensions of the platform are 21.25”w x 
19.00”l x 2.56”h. Sensors embedded in the platform produce an Anterior/Posterior 
Stability Score (APSS), a Medial/Lateral Stability Score (MLSS) and a person’s 
Overall Stability Index (OSI). These indexes are standard deviations assessing flux 
around the zero or central point (i.e. horizontal). The OSI is a composite of the MLSS 
and APSI and was the primary stability score used in this study.   
During the four balance tasks participants stood barefoot on the BioSway with 
eyes open and hands by their sides. To ensure measurement of normal balance, if a 
participant used a walking aid to balance day-to-day they were asked to use this aid 
whilst undertaking all study-related balance tasks. Foot position was taken in a 
comfortable position on the unstable surface prior to task commencement and the 
same foot position was used for each task. Participants stood on a stable surface 
during tasks 2 and 4 and an unstable surface for tasks 3 and 5. They were instructed 
to focus on holding their balance throughout single-task conditions (2 and 3) and to 
simultaneously focus on holding balance and saying aloud, in reverse order, 
numbers heard during dual-task conditions (4 and 5). OSI scores were calculated 
under single and dual-task conditions and dual-task decrement score calculated in 
terms of percentage change from single to dual-task conditions.  
 
Cognitive Task  
During one single and two dual-task conditions participants listened to 
sequences of digits at their individualised digit span length. Pre-recorded digit 
sequences were played aloud and participants were required to repeat each 
sequence in reverse order. Responses were recorded manually. Scores were 
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calculated by allocating one point for each digit in the correct place in a sequence. 
The total correct was then calculated. To obtain percentage correct scores, the total 
score was divided by the total possible correct score and multiplied by 100.  
 
Procedure  
At routine appointments, PwRRMS who met the study criteria were informed 
about the study by their Neuropsychologist, Neurologist, MS Nurse or MS Therapy 
Centre Manager. Those who expressed an interest were provided with the participant 
information sheet. If consent and contact information was provided, after 24 hours, 
the researcher contacted potential participants by telephone to provide further 
information regarding the study and answer any questions. Control participants 
contacted the researcher using contact details on the poster. If verbal consent was 
given, arrangements were made to meet and written consent was obtained.  
All participants completed baseline assessment measures as previously 
described. Subsequently, all participants undertook three single and two dual-tasks. 
Task 1 required participants to complete a titrated backward digit span task. Task 2 
involved participants standing on the BioSway platform, stable surface, for a total of 
80 seconds with a 15 second break half way. Task 3 involved participants standing 
on the BioSway platform, unstable surface, for 80 seconds with a 15 second rest half 
way. For Task 4, participants stood on the BioSway platform, stable surface, whilst 
simultaneously completing the backwards-span task. Task 5 required participants to 
stand on the BioSway platform, unstable surface, whilst completing the backwards-
span task. To ensure consistency of delivery, instructions for balance tasks were pre-
produced by the researcher and instructions for digit span were based on the 
backwards digit span subtest in the WAIS-IV [Pearson Education Ltd, 2008]. To 
control for order effect, task order was randomly assigned. A simple function in Excel 
was used to produce different combinations of 1-5 to ensure that the 68 participants 
completed the three single and two dual-tasks in a different order from one another.  
 
Results 
Data Analysis  
Distributions of all variables were examined for normality. All scores apart from 
age and DTQ were not normally distributed. Where appropriate, a parametric 
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approach was used and a non-parametric approach was adopted for all other scores. 
Descriptive statistics were produced to describe the data. Independent samples T-
tests and Mann-Whitney U tests were used as appropriate to compare groups on 
demographic information, baseline clinical features, and on single-task and dual-task 
performance. Using Mann-Whitney U-Test, measures of dual-task decrement (for 
balance and digit span tasks) were compared for both groups. Spearman correlations 
were used to examine whether there was a relationship between DTQ scores and 
individual dual-task decrement scores. Spearman Correlation coefficients (r) were 
used firstly to explore relationships between self-reported anxiety and depression 
and dual-task decrement scores and secondly, to examine disease severity (EDSS 
Score) and dual-task decrement scores in the MS group only. To balance risk of type 
I and II errors, a Bonferroni correction was applied - the level of significance was 
reduced by the number of correlations calculated for each factor. More specifically, 
four different correlations were derived for each factor; therefore the p-value was 
divided by four to reduce the likelihood of type I errors, whilst maintaining reasonable 
power. Therefore, the significance level became 0.0125 for these correlations. All 
effect sizes were reported as Cohen’s r for consistency.  
 
Descriptive Characteristics  
Data were collected for 35 RRMS and 34 control participants. Data for one 
RRMS participant could not be used due to a leg tremor during balance testing. Data 
included in statistical analysis were therefore taken from 34 PwRRMS and 34 healthy 
control participants. Demographic and clinical characteristics of each group are 
outlined in Table 1. There were no significant differences in age (t (df 66) = 0.207), 
gender (t (df 66) = 0.000), years of education (z=-1.101), estimated pre-morbid IQ 
(z=-1.695) or baseline digit span (z=-1.108) between the groups. A significant 
difference was found between groups for self-reported DTQ scores (p<0.001; d=2.30; 
r=0.75; t (df 66) = 9.476) - PwRRMS reported greater difficulty dual-tasking day-to-
day compared to controls. RRMS performance was significantly poorer on the ACE-
III compared to healthy controls (p<0.001; r=-0.76; z=-6.306). All thirty-four control 
subjects scored above the two clinical cut-offs compared to twenty-five RRMS 
participants. Five PwRRMS scored below the first cut-off (score of 88) and four 
scored below the second cut-off (score of 82). PwRRMS self-reported greater levels 
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of fatigue (p<0.001; r=-0.69; z=-5.683), depression (p<0.001; r=-0.55; z=-4.543) and 
anxiety (p<0.001; r=-0.43; z=-3.548) compared to controls.  
 
Performance under single and dual-task conditions  
 Data was analysed to establish performance on digit span and balance tasks 
under single and dual-task conditions. Significant differences were found between 
groups on all digit span tasks (single-task: z=-3.236, u=330, p<0.001, r=-0.39; dual-
task stable: z=-4.596, u=210, p<0.001, r=-0.56; dual-task unstable: z=-6.536, u=50, 
p<0.001, r=-0.79). Significant differences were also found between groups on all 
balance tasks (single stable: z=-4.683, u=204, p<0.001, r=-0.57; single unstable: z=-
5.189, u=159, p<0.001, r=-0.63; dual-task stable: z=-3.828, u=269, p<0.001, r=-0.46; 
dual-task unstable: z=-5.888, u=101, p<0.001, r=-0.71). Table 2 and Figure 1 
summarise RRMS and control participant performance on all single and dual-tasks.  
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 Table 1: Participant Demographic and Clinical Characteristics 
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      Table 2: RRMS and Control Participant Performance on all Single and Dual-tasks  
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   Figure 1: RRMS and Control Participant Median Performance on all Single and Dual-tasks  
   Note: Error bars represent lower-upper interquartile ranges for each of the median scores    
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Dual-task decrement   
Baddeley et al.’s (1997) formula was used to calculate percentage change 
(decrement) in performance from single to dual-task conditions [Baddeley, Della 
Sala, Gray, Papagno, & Spinnler, 1997].  
 
 
 
 
 
Percentage changes (decrements) in performance from single to dual-task conditions 
are outlined in Table 3 and Figure 2.  
 
Digit Span Performance  
 Statistically significant differences were found between RRMS and control 
participants in digit span performance decrement in stable (z=-3.417; p<0.001 two-
tailed; r=0.41) and unstable (z=-6.556; p<0.001 two-tailed; r=0.80) dual-task 
conditions. In the stable dual-task condition, RRMS participants’ performance 
decreased by 7% compared to 0% for controls. In the unstable dual-task condition, 
performance decreased by 20% in the RRMS group compared to 0% in the control 
group.  
 
Balance Task Performance   
 Statistically significant differences were found between RRMS and control 
groups in balance task performance decrement in unstable (z=-2.715; p=0.007 two-
tailed; r=0.33), but not stable (z=-0.413; p=0.679 two-tailed; r=0.05) dual-task 
conditions. A medium-large effect size was found for the unstable condition with 
overall stability decreasing by 25% in the RRMS group compared to 0% in the control 
group. No effect was found for the stable condition with RRMS overall stability 
decreased by 29% compared to 50% for controls.   
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      Table 3: Percentage Change (decrement) in Performance from Single to Dual-task 
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     Figure 2: Percentage Change (decrement) in Performance from Single to Dual-task 
     Note: Error bars represent lower-upper interquartile ranges for each of the median scores   
DClinPsy 2016 University of Glasgow 
 
 
59 
Correlational Analysis 
The relation between a measure of everyday dual-tasking (DTQ), fatigue 
(MFIS), a cognitive screening measure (ACE-III) and decrement scores for digit span 
and balance tasks were explored. The results are outlined in Table 4. No significant 
correlations were found between self-reported DTQ scores, self-reported MFIS 
scores, ACE-III scores and decrement scores under any of the dual-task conditions.  
The relation between disability status (EDSS), levels of anxiety and 
depression (HADS) and decrement scores were also explored. The results are 
outlined in Table 5. Stable surface balance decrement scores were significantly 
correlated with levels of anxiety (rho=0.527, p=0.001) and depression (rho=0.451, 
p=0.007). No significant correlations were found between EDSS and decrement 
scores under any of the dual-task conditions.   
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         Table 4: Correlation Between Measure of Divided Attention (DTQ), Fatigue (MFIS), a Cognitive Screen (ACE-III) and  
         Decrement Scores 
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              Table 5: Correlation Between Measure of Disability Status (EDSS), Levels of Anxiety and Depression (HADS) and  
              Decrement Scores 
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Discussion 
Consistent with hypothesis one, a main finding of the study was that PwRRMS 
show a greater decrement under dual-task conditions compared to single conditions 
on measures of balance, digit span and decrement scores when compared with 
controls. However, inconsistent with hypothesis one, with regard to balance, a 
significantly greater decrement was not found in the stable dual-task condition. 
Where statistically significant differences were found, effect sizes were medium–
large.  
On the stable balance condition, the percentage change in performance from 
single to dual-task conditions was higher in the control group (50%) compared to the 
RRMS group (29%) (see table 3), though this was not significant. One reason for the 
higher percentage change in the controls is that they started from a low baseline OSI 
level, so relatively modest changes (i.e. similar absolute level to those of the MS 
group), represent a higher percentage change. Somewhat anomalously, the median 
OSI scores were the same for controls and PwRRMS in both single stable and dual 
stable conditions, despite the median change scores being 50% and 29% 
respectively.  This results from the skewed distributions, and the difference in 
distributions of absolute scores and percentage change scores.   
Negahban et al. (2011) and Kalron et al. (2010) both found PwMS showed 
decreased postural control under dual-task conditions compared to controls. Two 
theoretical explanations have been proposed to account for the observed dual-task 
decrements in performance: The capacity model and the bottleneck model [Leone et 
al., 2015]. The capacity model proposes that the amount of cognitive resources 
available has a limit. Tasks are therefore completed within the capacity limits of those 
resources and dual-task decrements are apparent when the demands are greater 
than the resources. So when a cognitive task is added to a demanding motor task, 
then the system is overloaded and decrements occur. The question for this study 
though is why PwRRMS show greater decrements than controls. The cognitive task 
was titrated to individualised levels and so should have been requiring equal 
resources (unless we hypothesise that, due to working memory capacity being 
reduced in MS, the MS group require greater cognitive resources to produce a similar 
level of performance to that of the controls). For the motor task however, it may be 
argued that this was more difficult for the MS group, given that their performance 
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under single task conditions was poorer than controls. So if this task is demanding 
much higher level of cognitive resource, when a secondary cognitive task is added, 
the attentional capacity may be compromised to a greater extent than for controls.  
The bottleneck model suggests that decrements in dual-tasking occur due to 
both tasks attempting to use the same neuronal resources. There is some evidence 
from fMRI studies that working memory, spatial attention and locomotive tasks use 
similar neuronal resources [LaBar, Gitelman, Parrish, & Mesulam, 1999; Malouin, 
Richards, Jackson, Dumas, & Doyon, 2003]. In the present study, although the digit 
span task is a verbal task, so potentially not drawing on visual/motor system 
resources, some participants self-reported mentally visualising digit sequences as 
they heard them and reading them backwards using the visual representation as a 
memory aid. This spatial aspect of digit span, combined with the visual feedback 
component of the balance task, suggests that shared neuronal resources were being 
used and if the capacity of these shared resources is reduced in MS, then this may 
have resulted in a disproportionate decrement under dual-task conditions. 
Another potential explanation is that in MS there may be a central difficulty 
with dividing attention (even on tasks that are not making greater demands than 
usual) and that this makes it more difficult to efficiently allocate attention to two tasks 
simultaneously.  
In the present study, whilst the most likely explanation for the disproportionate 
decrements for PwRRMS is the capacity model, some combination of all three 
potential explanations cannot be ruled out, something that could be explored in future 
research. 
 
Factors affecting dual-tasking 
Stable surface balance decrement scores were significantly associated with 
levels of anxiety and depression in PwRRMS, but this relationship was not evident on 
the unstable surface. Effect sizes were medium–large. The correlation between 
anxiety/depression and decrement in performance suggests that adding a cognitive 
task does not have any greater effect on the balance of PwRRMS than it does on 
controls when on a stable surface, unless participants are experiencing higher levels 
of anxiety/depression, in which case balance begins to deteriorate. On the unstable 
surface, there was a significant difference between PwRRMS and controls at a group 
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level, but no association with anxiety/depression. Perhaps it is the case that 
difficulties with dual-tasking on the unstable surface are so great as a result of limited 
cognitive resources, that variations in anxiety/depression do not have any additional 
impact on a system that is already compromised.  
A previous relationship between postural stability and anxiety has been shown 
in different clinical groups. For example, Matsuura and colleagues (2015) assessed 
postural instability in patients with schizophrenia and control subjects, finding that 
postural instability was exacerbated by anxiety in the patient group only. However, 
the precise nature of the relationship between anxiety and dual-task decrement is not 
clear.  
Given that some of the conducted correlations were not statistically significant, 
it is important to consider the possibility of chance findings. Whilst a relatively 
conservative approach to significance level was adopted, nevertheless it is possible 
these were random errors.  
 
Dual-tasking and disease severity 
One may anticipate that dual-tasking performance may decrease as disability 
status increases. This effect has been found in previous studies [Boes et al., 2012]. 
However, the present study found no association between disease severity and dual-
task decrement scores. This lack of association was also found in other studies such 
as Hamilton et al (2009). A recent systematic review by Wajda and Sosnoff (2015) 
further highlighted the discrepancy in results regarding the association between 
decrement and disability status. They postulated that divergent methodologies might 
explain the differences.  
   
Everyday dual-tasking 
PwRRMS reported significantly higher levels of everyday dual-tasking 
difficulties compared to control subjects. However, inconsistent with hypothesis two, 
no correlation was found between measures of dual-task decrement and scores on 
the DTQ Questionnaire. Seemingly a range of factors other than the impact of 
cognitively demanding tasks on balance are affecting functioning on the dual-tasks 
covered in this questionnaire. Alternatively, measures of dual-task decrement in this 
balance study and the gait related DTQ Questionnaire perhaps tap into different 
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motor abilities. Future research should explore the relationship between balance and 
gait parameters in RRMS.  
 
Day-to-Day and Clinical Implications 
Results suggest that PwRRMS will have difficulties maintaining balance and 
performing cognitive tasks, when attempted simultaneously. Furthermore, results 
suggest that dual-tasking performance may decrease when PwRRMS have 
heightened levels of anxiety/depression. These findings have consequences on 
everyday life where we commonly hold our balance while concurrently attending to 
cognitive tasks, for example, standing having a conversation. A review by Cameron 
and Lord (2010) highlighted that PwMS commonly fall, display a fear of falling, are at 
greater risk of sustaining fall-associated injuries, and have increased risk of fatal falls. 
They also found that impairments of balance are probable causes of falls in PwMS. 
Postural instability under day-to-day dual-tasking conditions may therefore increase 
the risk of falls in PwMS.   
Explaining potential balance and cognitive dual-task difficulties and the 
associated impact of increased levels of anxiety/depression, may help to inform 
future clinical assessment and treatment planning. Present study findings propose 
that solely assessing balance may not translate to everyday balance ability, where 
additional tasks may need to be concurrently attended to. Assessing balance with 
and without a concurrent task may be a more reliable way of measuring dual-task 
abilities in clinical settings. The need to assess dual-task ability is further supported 
by the present study finding that dual-task decrement is not predicted by factors such 
as fatigue, disease severity, or general cognitive ability. Developing a clinical 
assessment that measures balance and cognitive performance under both single and 
dual-task conditions would be ideal but may not be practical for some clinical 
settings. Moreover, including measures of anxiety/ depression will be important in 
comprehensively assessing everyday dual-task difficulties in MS. Levels of 
anxiety/depression should also be considered when planning treatment of everyday 
dual-task difficulties - anxiety and mood management techniques could be applied 
and may improve dual-tasking, though this needs to be evaluated.  
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Limitations 
The present study had several limitations. Firstly, multiple Spearman 
correlations were conducted to test hypothesis two and to assess the impact mood 
has on dual-task performance, and although the accepted level of significance was 
reduced to try and control for type I and II errors, multiple correlations still raise the 
possibility of chance findings. Secondly, RRMS was the only form of MS scrutinised 
in this study therefore, it is unknown if the same dual-tasking effects would be found 
in other types of MS. Thirdly, the methods do not allow for differentiation between 
potential explanations for the disproportionate dual-task decrement.  
 
Future Research 
This was the first dual-tasking study in an RRMS population to manipulate 
task demand by using backwards digit span, and so should be replicated. This 
methodology could also be applied to different types of MS. Future studies could also 
explore the impact of this more cognitively demanding task on gait. Despite reporting 
significantly higher levels of everyday dual-tasking difficulties (DTQ) the level of 
difficulty was not explained by the severity of dual-task difficulties on the balance/digit 
span tasks measured by degree of dual-task decrement. It will be important to 
determine whether the DTQ questionnaire is a valid measure of everyday dual-
tasking difficulties and if so, what accounts for these difficulties. Furthermore, future 
work should also focus on developing a clinical tool to measure day-to-day balance 
and dual-tasking difficulties in MS.  
 
Conclusions 
RRMS causes difficulties with dual-tasking, impacting balance, particularly under 
challenging conditions, which may contribute to an increased risk of gait difficulties 
and falls. The striking relationship between anxiety/depression and dual-task 
decrement suggests that worry may be contributing to dual-task difficulties, and 
raises the possibility that therapeutic interventions aimed at managing worry may 
improve cognitive-motor dual-tasking.  
 
 
 
DClinPsy 2016 University of Glasgow 
 
 
67 
References 
 
Allali, G., Laidet, M., Assal, F., Armand, S., & Lalive, P. H. (2014). Walking while 
talking in patients with multiple sclerosis: the impact of specific cognitive loads. 
Neurophysiol Clin, 44, 87-93.  
 
Andersson, G., Hagman, J., Talianzadeh, R., Svedberg, A., & Larsen, H. (2002). 
Effect of cognitive load on postural control. Brain Research Bulletin, 58(1), 135-139.  
 
Baddeley, A. D., Della Sala, S., Gray, C., Papagno, C., & Spinnler, H. (1997). Testing 
central executive functioning with a pencil-and-paper test. In P. Rabbitt (Ed.), 
Methodology of frontal and executive functions. (pp. 61-80). Hove: Psychology Press.  
  
Biodex. (2015). Biosway Portable Balance System. Available at: 
http://www.biodex.com/sites/default/files/950460man_10202revd.pdf (Last Acessed 
22/01/15).  
 
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the 
Hospital Anxiety and Depression: An updated literature review. Journal of 
Psychosomatic Research, 52, 69-77.  
 
Boes, M. K., Sosnoff, J. J., Socie, M. J., Sandroff, B. M., Pula, J. H., & Motl, R. W. 
(2012). Postural control in multiple sclerosis: Effects of disability status and dual task. 
Journal of Neurological Sciences, 315, 44-48.  
 
Cameron, M. H., & Lord, S. (2010). Postural control in multiple sclerosis: Implications 
for fall prevention. Curr Neurol Neurosci Rep, 10, 407-412.  
 
Cattaneo, D., De Nuzzo, C., Fascia, T., Macalli, M., Pisoni, I., & Cardini, R. (2002). 
Risk of falls in subjects with multiple sclerosis. Arch Phys Med Rehabil, 83, 864-867. 
 
DClinPsy 2016 University of Glasgow 
 
 
68 
Cocchini, G., Della Sala, S., Logie, R. H., Pagani, R., Sacco, L., & Spinnler, H. 
(2004). Dual task effects of walking when talking in Alzheimer’s disease. Rev Neurolo 
(Paris), 160, 74-80.  
 
Denney, D. R., Sworowski, L. A., & Lynch, S.G. (2005). Cognitive impairment in three 
subtypes of multiple sclerosis. Archives of Clinical Neuropsychology, 20(8), 967-981.  
 
Donker S. F., Roerdink, M., Greven, A. J; & Beek, P. J. (2007). Regularity of center-
of-pressure trajectories depends on the amount of attention invested in postural 
control. Exp Brain Res, 181, 1-11.  
 
Evans, J. J., Greenfield, E., Wilson, B.A., & Bateman, A. (2009). Walking and talking 
therapy: Improving cognitive–motor dual-tasking in neurological illness. Journal of the 
International Neuropsychological Society, 15, 112-120. 
 
Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical power analyses 
using G*Power 3.1: Tests for correlation and regression analyses. Behavior 
Research Methods, 41, 1149-1160. 
 
Goretti, B., Niccolai, C., Hakiki, B., Sturchio, A., Falautano, M., Minacapelli, E., 
…Amato, M. P. (2014). The brief international cognitive assessment for multiple 
sclerosis (BICAMS): normative values with gender, age and education corrections in 
Italian population. BMC Neurology, 14(171), 1-6.  
 
Hamilton, F., Rochester, L., Paul, L., Rafferty, D., O’Leary, C.P., & Evans, J. J. 
(2009). Walking and talking: an investigation of cognitive-motor dual tasking in 
multiple sclerosis. Multiple Sclerosis, 00, 1-13.  
 
Hodges, J. R. (2007). Cognitive Assessment for Clinicians 2nd Edition. Oxford: Oxford 
University Press.  
 
DClinPsy 2016 University of Glasgow 
 
 
69 
Hobart, J., Lamping, D., Fitzpatrick, R., Riazi, A., & Thompson, A. (2001). The 
Multiple Sclerosis Impact Scale (MSIS-29); a new patient-based outcome measure. 
Brain, 124, 962-973.  
 
Hsieh, S., Schubert, S., Hoon, C., Mioshi, E., & Hodges, J. R. (2013). Validation of 
the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and 
Alzheimer’s disease. Dement Geriatr Cogn Disord. 36(3-4), 242-50.  
 
Jacobs, J. V., & Kasser, S. L. (2012). Effects of dual-tasking on the postural 
performance of people with and without multiple sclerosis: a pilot study. J Neurol, 
259, 1166-1176.  
 
James, M., Plant, G. T., & Warrington, E. K. (2001). Cortical vision screening test 
manual. Thames Valley Test Company Limited.  
 
Kalron, A., Dvir, Z., & Achiron, A. (2010). Walking while talking – difficulties incurred 
during the initial stages of multiple sclerosis disease process. Gait and Posture, 32, 
332-335.  
 
Kalron, A., Dvir, Z., & Achiron, A. (2011). Effect of a cognitive task on postural control 
in patients with a clinically isolated syndrome suggestive of multiple sclerosis. Eur 
Journal Phys Rehabil Med, 47, 579-586.  
 
Kos, D., Kerchofs, E., Carrea, I., Verza, R., Ramos, M., & Jansa, J. (2005). 
Evaluation of the Modified Fatigue Impact Scale in four different European countries. 
Multiple Sclerosis, 11(1), 76-80.  
 
LaBar, K. S., Gitelman, D. R., Parrish, T. B., & Mesulam, M. (1999). Neuroanatomic 
overlap of working memory and spatial attention networks: a functional MRI 
comparison within subjects. Neuroimage. 10, 695-704.  
 
DClinPsy 2016 University of Glasgow 
 
 
70 
Leone, C., Patti, F., & Feys, P. (2015). Measuring the cost of cognitive-motor dual 
tasking during walking in multiple sclerosis. Topical Review: Multiple Sclerosis, 21(2), 
123-131.  
 
Malouin, F., Richards, C. L., Jackson, P. L., Dumas, F., & Doyon, J. (2003). Brain 
activation during motor imagery of locomotor-related tasks: a PET study. Hum Brain 
Mapp. 19, 47-62.  
 
Matsuura, Y., Fujino, H., Hashimoto, R., Yasuda, Y., Yamamori, H., Ohi, K., …Imura, 
O. (2015). Standing postural instability in patients with schizophrenia: Relationships 
with psychiatric symptoms, anxiety, and the use of neuroleptic medications. Gait & 
Posture, 41, 847-851.  
 
Multiple Sclerosis Council for Clinical Practice (MSCCP) Guidelines. (1998). Fatigue 
and multiple sclerosis: evidence-based management strategies for fatigue in multiple 
sclerosis. Washington DC: Paralyzed Veterans of America.  
 
Multiple Sclerosis Trust (MS Trust). (2013). Expanded Disability Status Scale. 
Retrieved from http://www.mstrust.org.uk/atoz/edss.jsp [Last Accessed 01/12/14].  
 
Negahban, H., Mofateh, R., Arastoo, A. A., Mazaheri, M., Yazdi, M. J., Salavati, M., & 
Majdinasab, N. (2011). The effects of cognitive loading on balance control in patients 
with multiple sclerosis. Gait & Posture, 34, 479-484.  
 
Pearson Education Ltd. (2008). Wechsler Adult Intelligence Scale – Fourth UK 
Edition. Retrieved from 
http://www.pearsonclinical.co.uk/Psychology/AdultCognitionNeuropsychologyandLan
guage/AdultGeneralAbilities/WechslerAdultIntelligenceScale-FourthUKEdition(WAIS-
IVUK)/WechslerAdultIntelligenceScale-FourthUKEdition(WAIS-IVUK).aspx (last 
accessed 08/04/16).  
 
Pearson Education Ltd. (2010). Test of Premorbid Function – UK Edition. 
Administration, Scoring and Technical Manual. London: Pearson Education Inc.  
DClinPsy 2016 University of Glasgow 
 
 
71 
 
Polman, C. H., Reingold, S. C; Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., 
…Wolinsky, J. S. (2010). Diagnostic criteria for multiple sclerosis: 2010 revisions to 
the McDonald Criteria. American Neurological Association, 69, 292-302.  
 
Rogers, J. M., & Panegyres, P. K. (2007). Cognitive impairment in multiple sclerosis: 
Evidence-based analysis and recommendations. Journal of Clinical Neuroscience, 
14, 919-927.  
 
Shumway-Cook, A., & Woolacott, M. (2000). Motor Control: Theory and Practical 
Applications, 2nd ed. Baltimore: Lippincott, Williams and Wilkens.  
 
Wajda, D. A., Motl, R. W., & Sosnoff, J. J. (2014). Correlates of dual task cost of 
standing balance in individuals with multiple sclerosis. Gait & Posture, 40, 352-356.  
 
Wajda, D. A., & Sosnoff, J. J. (2015). Cognitive-motor interference in Multiple 
Sclerosis: a systematic review of evidence, correlates, and consequences. Hindawi, 
1-8. http://dx.doi.org/10.1155/2015/720856  
 
Wechsler, D. (2011). Test of Premorbid Functioning – U.K. Version. Retrieved from 
http://www.pearsonclinical.co.uk/Psychology/AdultCognitionNeuropsychologyandLan
guage/AdultGeneralAbilities/TOPF/TestofPremorbidFunctioning.aspx (Last Accessed 
01/12/14).  
 
Whelan, R., Lonergan, R., Kiiski, H., Nolan, H., Kinsella, K., Hutchison, M., …Reilly, 
R. B. (2010). Impaired information processing speed and attention allocation in 
multiple sclerosis patients versus controls: A high-density EEG study. Journal of 
Neurological Sciences, 293, 45-50.  
 
Wood, B., van der Mei, I. A., Ponsonby, A. L., Pittas, F., Quinn, S., Dwyer, T., 
…Taylor, B. V. (2012). Prevalence and concurrence of anxiety, depression and 
fatigue over time in multiple sclerosis. Multiple Sclerosis Journal, 0(0), 1-8.  
 
DClinPsy 2016 University of Glasgow 
 
 
72 
Woollacott, M., & Shumway-Cook, A. (2002). Attention and the control of posture and 
gait: a review of an emerging area of research. Gait and Posture, 16, 1-14.  
 
Yogev-Seligmann, G., Hausdorff, J. M., & Giladi, N. (2008). The role of executive 
function and attention in gait. Movement Disorders, 23(3), 329-342.  
 
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. 
Acta Psychiatr Scand. 67, 361-370. 
  
DClinPsy 2016 University of Glasgow 
 
 
73 
APPENDICES 
 
Appendices: Systematic Review      Page 
1.1 Author Guidelines Journal of the International      74 
Neuropsychological Society        
1.2  Quality Rating Protocol        76 
1.3  Quality Ratings for all Included Studies        79 
1.4   Data Extraction Form          80 
 
Appendices: Major Research Project 
2.1  Author Guidelines Journal of the International      82 
  Neuropsychological Society  
2.2  Ethical Approval Letter I        84 
2.3   Ethical Approval Letter II        88 
2.4  Research and Development Approval Letter     92 
2.5  Participant Consent Form (MS)       94 
2.6  Participant Consent Form (Controls)      96 
2.7  Participant Information Sheet (MS)       98 
2.8  Participant Information Sheet (Controls)     102 
2.9  Major Research Project Proposal      106 
2.10   Dual Task Questionnaire       128 
2.11  Baseline Digit Span Assessment Sheet      129 
2.12   Single Task Digit Span Assessment Sheet     130 
2.13   Dual-task 1 Digit Span Assessment Sheet     131 
2.14   Dual-task 2 Digit Span Assessment Sheet      132 
      
 
 
 
 
 
 
DClinPsy 2016 University of Glasgow 
 
 
74 
Appendix 1.1  
 
 
 
DClinPsy 2016 University of Glasgow 
 
 
75 
 
 
 
 
 
 
 
DClinPsy 2016 University of Glasgow 
 
 
76 
Appendix 1.2 
Quality Rating Protocol 
 
SECTION 1: INTERNAL VALIDITY 
 
Study Question 
                 Circle Response 
 
1.1 
 
The study addresses an appropriate and 
clearly focused question.  
 
 
Yes                 No 
 
Can’t Say  
 
 
Selection of Subjects 
 
 
1.2 
 
The cases and controls are taken from 
populations that are comparable in all 
respects other than the factor under 
investigation e.g. age, gender, socio-
economic status.  
 
 
 
Yes                 No 
 
Can’t Say  
 
 
1.3 
 
The same exclusion criteria are used for both 
cases and controls.  
 
Controls will differ in one exclusion criteria with 
regards to disease status e.g. will not have 
diagnosis of Multiple Sclerosis.   
 
 
Yes                 No 
 
Can’t Say  
 
1.4 
 
Comparison is made between participants 
(case and controls) and non-participants 
(eligible but did not take part) to establish their 
similarities and differences.  
 
 
Yes                 No 
 
Can’t Say  
 
 
1.5 
 
 
Cases are clearly defined and differentiated 
from controls.  
 
Yes                 No 
 
Can’t Say  
 
 
1.6 
 
 
It is clearly established that controls are non-
cases.  
 
 
Yes                 No 
 
Can’t Say  
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Assessment  
 
 
1.7 
 
 
Exposure status is measured in a standard, 
valid and reliable way. 
 
Yes                 No 
 
Can’t Say  
 
 
 
1.8 
 
 
Evidence from other sources is used to 
demonstrate that the method of outcome 
assessment is valid and reliable.  
 
Yes                 No 
 
Can’t Say  
 
 
Confounding 
 
 
1.9 
 
 
The main potential confounders are identified 
and taken into account in the design and 
analysis.    
 
Yes                 No 
 
Can’t Say  
 
 
Statistical Analysis  
 
 
1.10 
 
 
Confidence intervals have been provided.  
 
Yes                 No 
 
Can’t Say  
 
 
SECTION 2: OVERALL ASSESSMENT OF THE STUDY   
 
                 Circle Response 
 
2.1  
 
 
How well was the study done to minimise the 
risk of bias or confounding? 
 
 
High quality (++) = Majority of criteria met (7 or 
more yes responses). Little or no risk of bias.  
Results unlikely to be changed by further 
research. 
 
Acceptable (+) = Most of criteria met (5 or more 
yes responses). Some flaws in the study with an 
associated risk of bias. Conclusions may change 
in the light of other studies.   
 
Unacceptable (0) = Either most criteria not met or 
significant flaws relating to key aspects of study 
design. Conclusions likely to change in the light of 
further studies.  
 
 
 
High quality (++) 
 
Acceptable (+) 
 
Unacceptable (0)  
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2.2 
 
 
Taking into account clinical considerations, 
your evaluation of the methodology used and 
the statistical power of the study, do you think 
there is clear evidence of an association 
between exposure and outcome?  
 
 
Yes                 No 
 
Can’t Say  
 
 
2.3 
 
 
Are the results of this study directly applicable 
to the patient group targeted by this review?  
 
 
Yes                 No 
 
 
 
 
NOTES 
Add any comments on your own assessment of the study and the extent to which it 
answers your question. Mention any areas of uncertainty raised above.  
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Appendix 1.3  
Quality Ratings of Included Studies  
 
                             
                                 
Question No: 
 
Study: 
 
1.1 
 
 
1.2 
 
 
1.3 
 
 
1.4 
 
1.5 
 
 
1.6 
 
1.7 
 
 
1.8 
 
1.9 
 
1.10 
 
2.1 
 
2.2 
 
2.3 
Claros-Salinas et al, 2013 Y Y CS N Y CS Y CS N Y + CS Y 
Devos et al, 2013 Y Y Y N Y Y Y Y N N ++ Y Y 
McCarthy et al, 2005 Y Y CS N Y CS Y CS N N 0 Y Y 
Patanella et al, 2010 Y Y Y N Y CS Y N N N + Y Y 
Paul et al, 1998 Y Y Y N Y Y Y N N N + Y Y 
Ruet et al, 2013 Y Y Y N Y Y Y N Y N ++ Y Y 
De Sonneville et al, 2002 Y Y CS N Y CS Y N N N 0 CS Y 
Stoquart-ElSankari et al, 
2010 
Y Y CS N Y CS Y Y Y N + Y Y 
 
Note: Letter score criteria: Y = Yes; N = No; CS = Can’t Say. Overall Quality Rating (question 2.1) Score Criteria: ++ = high 
quality; + = acceptable; 0 = low quality.   
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Appendix 1.4  
Data Extraction Form 
Study Characteristics 
Study purpose or aims:  
 
 
 
Study inclusion and exclusion criteria:  
Inclusion:  
 
 
Exclusion:  
 
 
Participant Characteristics 
Age Range MS Group: 
Age Range Control Group:   
Gender MS Group: 
Gender Control Group:  
Type of MS:  
Disease stage / EDSS Score (MS only):  
 
Recruitment 
n MS:  
n Control Group:  
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How were MS participants recruited:  
 
 
 
How were Control participants recruited:  
 
 
 
Measures 
What were the measures of divided attention:  
 
 
 
 
Results 
Type of analysis used:  
  
 
Conclusion:  
 
 
 
Quality Rating (SIGN-MC4): _______________________________   
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Appendix 2.5  
 
 
 
 
 
 
 
 
 
 
 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
 
CONSENT FORM 
(For those with a diagnosis of Multiple Sclerosis) 
 
Title of Project: “An Investigation of Balance and Dual-Tasking in Multiple Sclerosis” 
 
Name of Researcher: Emma-Louise Butchard 
 
          Please initial box 
 
 
 
1 I confirm that I have read and understand the information sheet 
dated ............................ (version ............) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
 
 
2 I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected. 
 
 
 
3 I understand that relevant sections of my medical notes and data collected during 
the study, may be looked at by individuals from regulatory authorities or from the 
NHS Trust, where it is relevant to my taking part in this research.  I give permission 
for these individuals to have access to my records. 
 
 
 
4 I agree to my GP being informed of my participation in the study. 
    
 
 
5 I agree to take part in the above study.  
    
 
 
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________________________ ________________ ____________________ 
Name of Patient Date Signature 
 
 
 
 
 
_________________________ ________________ ____________________ 
Name of Person taking consent Date Signature 
(if different from researcher) 
 
 
 
 
_________________________ ________________ ____________________ 
Researcher Date Signature 
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Appendix 2.6 
 
 
 
 
 
 
 
 
 
 
 
Centre Number: 
Study Number: 
Patient Identification Number for this trial: 
 
CONSENT FORM 
(For Healthy Volunteers) 
 
Title of Project: “An Investigation of Balance and Dual-Tasking in Multiple Sclerosis” 
 
Name of Researcher: Emma-Louise Butchard 
 
          Please initial box 
 
 
 
1 I confirm that I have read and understand the information sheet 
dated ............................ (version ............) for the above study.  I have had the 
opportunity to consider the information, ask questions and have had these 
answered satisfactorily. 
 
 
 
2 I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being 
affected. 
 
 
 
3 I agree to my GP being informed of my participation in the study. 
 
 
 
4 I agree to take part in the above study. 
    
 
 
    
 
 
 
________________________ ________________ ____________________ 
Name of Patient   Date Signature 
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_________________________ ________________ ____________________ 
Name of Person taking consent Date  Signature 
(if different from researcher) 
 
 
 
 
 
_________________________ ________________ ____________________ 
Researcher   Date 
 Signature 
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Appendix 2.7  
 
 
 
 
 
 
 
 
“An Investigation of Balance and Dual-Tasking in Multiple Sclerosis” 
 
Participant Information Sheet 
(For those with a diagnosis of Multiple Sclerosis) 
 
Invitation to take part in the research 
You are invited to take part in a research project. We are looking for adults aged from 17 to 
65 years old who have a diagnosis of Relapsing Remitting Multiple Sclerosis (RRMS), have 
had no previous neurological conditions (e.g. Traumatic Brain Injury; Stroke), do not have 
severe sensory deficits (e.g. partial or complete blindness), and do not have health 
conditions which significantly impact on their motor abilities (e.g. severe, uncontrolled 
diabetes).   
 
Before deciding whether you want to participate or not it is important to understand why this 
research is being carried out and what taking part will involve. This information is outlined 
below. Please take the time to read this carefully and, if you wish, discuss it with others. If 
there is anything that is unclear or you would like more information on, please do not hesitate 
to ask. Take time to decide whether you would like to take part. Thank you for taking the time 
to read this information sheet.  
 
Who is conducting the research? 
The research project is being conducted by Emma-Louise Butchard (Trainee Clinical 
Psychologist), Dr Jim Law (Clinical Psychologist) and Professor Jonathan Evans from the 
Institute of Health and Well-being at the University of Glasgow. The study is being carried out 
to fulfil academic requirements for Glasgow University’s Doctorate in Clinical Psychology 
degree course.  
 
What is the purpose of the study? 
(i) Background 
Multiple sclerosis (MS) can cause a wide range of different difficulties, including physical 
(e.g. walking, balance), cognitive (e.g. memory and concentration) and emotional (e.g. low 
mood). Difficulties vary a lot between people with MS, and not everyone has difficulties in all 
these areas. In this project we are particularly interested in how different problems interact. 
Specifically, we are interested in balance and how it might be affected by engaging in mental 
activity. Previous work by our research group has shown that some people with MS have 
difficulties walking and talking at the same time. So doing two things at the same time (dual-
tasking) is difficult. In this project we are investigating how balance is affected when people 
are engaged in mental activity at the same time. It is possible that difficulties with dual-
tasking might be related to increased risk of trips and falls. If we find that balance is affected 
by engaging in other mental activities, this may therefore help us identify people who are 
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more vulnerable to falls and in the longer term we hope to develop rehabilitation strategies 
that help people with MS manage these dual-tasking difficulties.  In this project we will 
measure balance under single-task (simple standing) and dual-task (standing whilst doing a 
simple mental activity). In addition we will investigate whether a short questionnaire that we 
have developed, called the Divided Attention (DivA) questionnaire is useful in examining 
difficulties with doing two things at the same time in everyday situations for people with MS.  
(ii) Aims 
To investigate: (1) Whether individuals with Multiple Sclerosis have greater difficulties with 
balance and cognitive-motor dual-tasking compared to people who do not have MS; and (2) 
If there is a relationship between dual-task performance and scores on a divided attention 
questionnaire namely DivA. 
 
What does taking part involve? 
If you would like to take part, we will arrange a time convenient to you to come along and 
meet our researcher at the Neuropsychology Department at Raigmore Hospital. Participation 
involves completing assessment and balance tasks which in total will take approximately 1 
hour and 20 minutes. The assessment will include completing tasks such as a questionnaire 
about your mood, the DivA questionnaire mentioned above, and some short pen and paper 
tasks (e.g. puzzles and language tasks). The balance task involves standing on a machine 
called the BioSway which looks a bit like a scale. You will be given the opportunity to 
familiarise yourself and have a practice with the BioSway. You can take breaks during the 
testing. With your permission, we will also inform your GP that you are participating in this 
study.  
 
What are the possible benefits of taking part? 
Research gives us the opportunity to improve our knowledge about various difficulties people 
with MS may experience. Your participation in this study will help us increase our knowledge 
about balance and attention difficulties in individuals with MS and help us make 
improvements to assessment methods and treatment in the future.  
 
What are the possible risks or disadvantages of taking part? 
There are no significant risks or disadvantages of taking part in this study. As balance is 
being tested you may feel slightly unsteady on your feet. To minimise risk, you will be given 
the opportunity to familiarise yourself with the balance machine (BioSway) to decide if you 
want to take part in the study or not and the researcher will stand at your side to offer support 
if needed e.g. give you a hand to step off the BioSway. 
 
Regular breaks will be taken during the study to avoid you feeling tired. Although we do not 
predict that participating in this study will cause you any distress, if this were to happen we 
would help you access appropriate support.  
 
Do I have to take part? 
It is up to you whether you decide to take part in this study. If you decide you want to take 
part, you will be given a copy of this information sheet to keep and be asked to sign a 
consent form. Although you will be signing the consent form, please be aware that you are 
free to withdraw from the study at any time. A decision to withdraw from the study or not take 
part at all will have absolutely no impact on the standard of care you receive.  
 
Will my information be confidential? 
All information collected about you during the study will be kept strictly confidential. If any 
information about you was required to leave the hospital, your name and address will be 
removed so that you cannot be recognised from it.  
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What happens to the information? 
Your personal information and identity will be kept strictly confidential and known only by the 
researchers. Information will be stored within a locked filing cabinet in the locked Psychology 
Department. All information will be held in accordance to the Data Protection Act (1998), 
meaning that it be stored securely and not shared with other people without your permission. 
If any findings from this study are published, your identity will be anonymised so you are not 
identifiable.   
 
What will happen to the results of the study? 
At the end of the study, the finished report will be submitted to the University of Glasgow. We 
hope that the findings will be published in a medical journal and through other sources to 
make sure the general public know what the study found. Your identity and personal 
information will not be reported or published following this study.  
 
Who is funding the research? 
The research is funded by the Doctorate in Clinical Psychology course at the University of 
Glasgow.  
 
Who has reviewed the study? 
The study has been reviewed by Glasgow University to make sure that it meets standards 
outlined regarding scientific conduct. The Proportionate Review Sub-Committee of the NRES 
Committee East Midlands – Nottingham 2 has also reviewed this study to make sure that it 
meets standards outlined regarding ethical conduct.  
 
Who can I contact for further information?  
If you would like any additional information or have any questions, please do not hesitate to 
contact a member of the research team on the below contact details. 
 
RESEARCH TEAM:  
Name Role Contact 
 
Emma-Louise Butchard 
 
 
Trainee Clinical 
Psychologist, NHS Highland 
 
 
Drumossie Unit 
New Craigs Hospital 
Inverness, IV3 8NP 
 
Tel: 01463 253 632 
 
 
Professor Jon Evans 
 
 
Academic Supervisor, 
University of Glasgow  
 
 
University of Glasgow 
1st Floor, Administration 
Building, Gartnaval Royal 
Hospital, 1055 Great 
Western Road, Glasgow, 
G12 0XH  
 
Tel: 0141 211 0607 
 
 
Dr Jim Law  
and 
Dr Louise Blackmore 
 
 
Field Supervisors, NHS 
Highland 
 
Drumossie Unit 
New Craigs Hospital 
Inverness, IV3 8NP 
 
Tel: 01463 253 632 
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Alternatively, if you would like to speak to someone independent to the study please use the 
below contact details. Please also use the independent contact information if you wish to 
raise a complaint.  
 
INDEPENDENT CONTACT: 
 
Name  Role Contact 
 
Professor Thomas McMillan 
 
 
Independent Contact, 
University of Glasgow 
 
 
University of Glasgow 
1st Floor, Administration 
Building, Gartnaval Royal 
Hospital, 1055 Great 
Western Road, Glasgow, 
G12 0XH  
 
Tel: 0141 211 0607 
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Appendix 2.8  
 
 
 
 
 
 
 
 
“An Investigation of Balance and Dual-Tasking in Multiple Sclerosis” 
 
Participant Information Sheet 
(For Healthy Volunteers) 
 
Invitation to take part in the research 
You are invited to take part in a research project. The project is investigating dual-tasking in 
people with Multiple Sclerosis (MS), but in addition to people with MS, we need a group of 
healthy people with whom to compare the participants with MS. We are therefore looking for 
adults aged from 17 to 65 years old who are generally healthy, do not have a diagnosis of 
Multiple Sclerosis, have had no previous neurological conditions (e.g. Traumatic Brain Injury; 
Stroke), do not have severe sensory deficits (e.g. partial or complete blindness), and do not 
have health conditions which significantly impact on their motor abilities (e.g. severe, 
uncontrolled diabetes).  
 
Before deciding whether you want to participate or not it is important to understand why this 
research is being carried out and what taking part will involve. This information is outlined 
below. Please take the time to read this carefully and, if you wish, discuss it with others. If 
there is anything that is unclear or you would like more information on please do not hesitate 
to ask. Take time to decide whether you would like to take part. Thank you for taking the time 
to read this information sheet.  
 
Who is conducting the research? 
The research project is being conducted by Emma-Louise Butchard (Trainee Clinical 
Psychologist), Dr Jim Law (Clinical Psychologist) and Professor Jonathan Evans from the 
Institute of Health and Well-being at the University of Glasgow. The study is being carried out 
to fulfil academic requirements for Glasgow University’s Doctorate in Clinical Psychology 
degree course.  
 
What is the purpose of the study? 
(i) Background 
Multiple sclerosis (MS) can cause a wide range of different difficulties, including physical 
(e.g. walking, balance), cognitive (e.g. memory and concentration) and emotional (e.g. low 
mood). Difficulties vary a lot between people with MS, and not everyone has difficulties in all 
these areas. In this project we are particularly interested in how different problems interact. 
Specifically, we are interested in balance and how it might be affected by engaging in mental 
activity. Previous work by our research group has shown that some people with MS have 
difficulties walking and talking at the same time. So doing two things at the same time (dual-
tasking) is difficult. In this project we are investigating how balance is affected when people 
are engaged in mental activity at the same time. It is possible that difficulties with dual-
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tasking might be related to increased risk of trips and falls. If we find that balance is affected 
by engaging in other mental activities, this may therefore help us identify people who are 
more vulnerable to falls and in the longer term we hope to develop rehabilitation strategies 
that help people with MS manage these dual-tasking difficulties.  In this project we will 
measure balance under single-task (simple standing) and dual-task (standing whilst doing a 
simple mental activity). In addition we will investigate whether a short questionnaire that we 
have developed, called the Divided Attention (DivA) questionnaire is useful in examining 
difficulties with doing two things at the same time in everyday situations for people with MS.  
(ii) Aims 
To investigate: (1) Whether individuals with Multiple Sclerosis have greater difficulties with 
balance and cognitive-motor dual-tasking compared to healthy control subjects; and (2) If 
there is a relationship between dual-task performance and scores on a divided attention 
questionnaire namely DivA. 
 
What does taking part involve? 
If you would like to take part, we will arrange a time convenient to you to come along and 
meet our researcher at the Neuropsychology Department at Raigmore Hospital. Participation 
involves completing assessment and balance tasks which in total will take approximately 1 
hour and 20 minutes. The assessment will include completing tasks such as a questionnaire 
about your mood, the DivA questionnaire mentioned above, and some short pen and paper 
tasks (e.g. puzzles and language tasks). The balance task involves standing on a machine 
called the BioSway which looks a bit like a scale. You will be given the opportunity to 
familiarise yourself and have a practice with the BioSway. You can take breaks during the 
testing. With your permission, we will also inform your GP that you are participating in this 
study.  
 
What are the possible benefits of taking part? 
Research gives us the opportunity to improve our knowledge about various difficulties people 
have. We are able to use this information in clinical settings to increase people’s quality of 
life. Your participation in this study will help us increase our knowledge about balance and 
attention difficulties in individuals with Multiple Sclerosis and help us make improvements to 
assessment and treatment in the future.  
 
What are the possible risks or disadvantages of taking part? 
There are no significant risks or disadvantages of taking part in this study. As balance is 
being tested you may feel slightly unsteady on your feet. To minimise risk, you will be given 
the opportunity to familiarise yourself with the balance machine (BioSway) to decide if you 
want to take part in the study or not and the researcher will stand at your side to offer support 
if needed e.g. give you a hand to step off the BioSway. If you feel as if you will fall the task 
will be stopped immediately.  
 
Regular breaks will be taken during the study to avoid you feeling tired. Although we do not 
predict that participating in this study will cause you any distress, if this were to happen we 
would help you access appropriate support. With your permission, we will notify your GP that 
you are taking part in the study.  
 
Do I have to take part? 
It is up to you whether you decide to take part in this study. If you decide you want to take 
part, you will be given a copy of this information sheet to keep and be asked to sign a 
consent form. Although you will be signing the consent form, please be aware that you are 
free to withdraw from the study at any time. A decision to withdraw from the study or not take 
part at all will have absolutely no impact on the standard of care you receive.  
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Will my information be confidential? 
All information collected about you during the study will be kept strictly confidential. If any 
information about you was required to leave the hospital, your name and address will be 
removed so that you cannot be recognised from it.  
 
What happens to the information? 
Your personal information and identity will be kept strictly confidential and known only by the 
researchers. Information will be stored within a locked filing cabinet in the locked Psychology 
Department. All information will be held in accordance to the Data Protection Act (1998), 
meaning that it be stored securely and not shared with other people without your permission. 
If any findings from this study are published, your identity will be anonymised so you are not 
identifiable.   
 
What will happen to the results of the study? 
At the end of the study, the finished report will be submitted to the University of Glasgow. We 
hope that the findings will be published in a medical journal and through other sources to 
make sure the general public know what the study found. Your identity and personal 
information will not be reported or published following this study.  
 
Who is funding the research? 
The research is funded by the Doctorate in Clinical Psychology course at the University of 
Glasgow.  
 
Who has reviewed the study? 
The study has been reviewed by Glasgow University to make sure that it meets standards 
outlined regarding scientific conduct. The Proportionate Review Sub-Committee of the NRES 
Committee East Midlands – Nottingham 2 has also reviewed this study to make sure that it 
meets standards outlined regarding ethical conduct.  
 
Who can I contact for further information?  
If you would like any additional information or have any questions, please do not hesitate to 
contact a member of the research team on the below contact details.  
 
RESEARCH TEAM:  
Name Role Contact 
 
Emma-Louise Butchard 
 
 
Trainee Clinical 
Psychologist, NHS Highland 
 
 
Drumossie Unit 
New Craigs Hospital 
Inverness, IV3 8NP 
 
Tel: 01463 253 632 
 
 
Professor Jon Evans 
 
 
Academic Supervisor, 
University of Glasgow  
 
 
University of Glasgow 
1st Floor, Administration 
Building, Gartnaval Royal 
Hospital, 1055 Great 
Western Road, Glasgow, 
G12 0XH  
 
Tel: 0141 211 0607 
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Dr Jim Law  
and 
Dr Louise Blackmore 
 
 
Field Supervisors, NHS 
Highland 
 
Drumossie Unit 
New Craigs Hospital 
Inverness 
IV3 8NP 
 
Tel: 01463 253 632 
 
 
Alternatively, if you would like to speak to someone independent to the study please use the 
below contact details. Please also use the independent contact information if you wish to 
raise a complaint.  
 
INDEPENDENT CONTACT: 
 
Name  Role Contact 
 
Professor Thomas McMillan 
 
 
Independent Contact, 
University of Glasgow 
 
 
University of Glasgow 
1st Floor, Administration 
Building, Gartnaval Royal 
Hospital, 1055 Great 
Western Road, Glasgow, 
G12 0XH  
 
Tel: 0141 211 0607 
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An Investigation of Balance and Cognitive-Motor Dual-Tasking in Multiple 
Sclerosis  
 
Background: Cognitive impairment is common in Multiple Sclerosis (MS), adding 
considerably to disease burden [41]. Dual-task designs, where participants perform 
cognitive and motor tasks concurrently, were used to investigate association between 
cognitive functioning and posture [2]. Studies show dual-task performance is 
impaired in people with MS (PwMS) compared to control subjects [5;18]. Evidence 
highlights deficits in attention and postural stability in MS but is scant regarding the 
association between these factors in PwMS. Aims: To investigate: (1) whether 
individuals with MS have increased difficulties with balance and cognitive-motor dual-
tasking compared to healthy control subjects; (2) If there is a relationship between 
dual-task performance and scores on a self-report divided attention questionnaire 
namely DivA [15]. Methods: 34 participants with MS and 34 matched controls will 
provide demographic details, complete baseline assessment measures and DivA 
questionnaires. Subsequently, all will undertake three single tasks and two dual-
tasks. Balance will be measured using the BioSway Portable Balance System [42], 
which measures neuromuscular control. The cognitive task is backwards digit-span 
[8]. Task order will be randomly assigned. Applications: Given the impact of disease 
burden, if PwMS have increased difficulty with balance and dual-tasking it will be 
pertinent to incorporate this knowledge clinically. For example, devising day-to-day 
management strategies will impact on symptom management and quality of life and 
inform treatment plans in various settings such as Rehabilitation and Psychology.  
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Introduction 
Cognitive impairment is common in Multiple Sclerosis (MS), occurs at all disease 
stages and can be a primary source of social impairment, occupational disability and 
diminished quality of life [30;32;7]. Estimated prevalence of cognitive impairment in 
people with MS (PwMS) ranges between 43% and 65% [9]; typically involving 
difficulty with complex attention, memory, information processing speed and 
executive functions [20;13]. Whelan et al (2010) examined an event-related potential 
that indexes processing speed and attention allocation in PwMS and control subjects, 
and compared these findings to results of the paced auditory serial addition test 
(PASAT).  Evidently both attention allocation and processing speed were impaired 
compared with control subjects.  
 
Balance and gait difficulties and associated risk of falling in PwMS are well known 
[27;14;6;24]. Where balance/gait is impaired, greater attention allocation may be 
required to maintain effective balance/gait. Postural control has been defined as, “the 
control of the body’s position in space for the purposes of balance and orientation” 
[33]. Conventionally it has been considered a reflex or automatic controlled task, 
proposing that minimal attentional resource is used by postural control systems [38]. 
New research offers evidence contradicting this hypothesis, suggesting substantial 
attentional requirements for postural control [10;31;39].  
 
Dual-task designs, where participants perform cognitive and motor tasks 
concurrently, have been used to investigate the possible association between 
cognitive functioning and posture [2]. Boes and associates (2012) investigated the 
effects of dual-tasking on postural control in PwMS with mild or moderate disability. 
Participants undertook posturography testing under a quiet single-task and cognitive 
dual-task condition. Results found postural control compromised by dual-task and 
declined with disability status. Moreover, a small amount of studies further suggest 
that PwMS display significant decrement in balance and gait under dual-task 
conditions when compared to control subjects [15;5;21;18]. Additionally, some 
research concludes that poor postural control contributes to increased risk of falling 
for PwMS [5;6;12]. However, other studies indicate no decrement to gait and 
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cognition under dual-task conditions [2;28;1]. Varying results within the evidence-
base warrant further investigation of balance and gait decrement in PwMS; 
particularly towards understanding the impact of dual-tasking on the cognitive domain 
[35] and to explore further causal factors of dual-task cost [24].  
 
Possible explanations for the development of dual-tasking decrements are currently 
few. One is that damage to motor functioning ultimately leads to greater demand of 
conscious attention while performing multiple tasks [21]. Another alternative is that in 
certain neurological disorders, working memory is overloaded by formerly normal 
loads of cognitive and motor content, resulting in reduced capacity [15;21] and poor 
balance or gait [24].  
 
To determine if difficulties with dual-tasking are exclusive to divided attention process 
impairment, it is crucial to ensure level of demand is set according to individual ability 
based on performance under single-task conditions. For example, Hamilton et al 
(2009) examined the effects of performing a simultaneous cognitive task when 
walking in PwMS. Results found that, in comparison to control participants, MS 
subjects showed larger decrements in performance in dual-task conditions in 
cognitive task performance, suggesting impairment in divided attention. 
Consequently, by using individual ability as our titrated divided attention measure, we 
are able to determine any true association between attention and balance and 
resulting dual-task decrement.  
 
Emerging evidence suggests that deficits in attention and balance/gait are present in 
MS. However, there is paucity in evidence regarding the association between these 
factors in PwMS. If true that for some PwMS balance/gait difficulties are either 
apparent or disproportionally impaired only under dual-task condition, then it may be 
prudent to measure this routinely in clinical practice. The twofold aim of this study is 
to investigate: (1) if individuals with MS have increased difficulties with balance and 
cognitive-motor dual-tasking compared to control subjects; (2) if there is a 
relationship between dual-task performance and scores on a self-report 
questionnaire, namely DivA [15], measuring divided attention in individuals with MS.  
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Hypotheses 
1. Compared to healthy controls, individuals with MS will show a greater 
decrement under dual-task conditions compared to single task conditions on 
measures of balance, digit span, and a combined decrement score.  
2. There will be a significant correlation between measures of dual-task 
decrement and scores on the Divided Attention Questionnaire. 
 
Plan of Investigation 
(i) Participants 
Participants will be persons with a diagnosis of Relapsing Remitting MS (RRMS) 
(mild or moderate presentation) and control subjects matched for age and gender. 
The aim is to recruit 34 participants for each group. MS participants will be recruited 
through NHS Highland Neuropsychology service, Neurology, Physiotherapy, MS 
Nurses and the MS Therapy Centre. Control participants will include a convenience 
sample of friends/family/spouses of MS participants and others will be recruited 
through NHS email poster or NHS noticeboard advertisement and displayed in 
Inverness hospitals, MS Therapy Centre or community venues.  
 
(ii) Inclusion and Exclusion Criteria  
Inclusion  
 Inclusion criteria for MS participants:  
o Age range 17-65 
o Diagnosis of RRMS. There are 4 subtypes of MS, however, to reduce 
variability in an already variable disease, only participants with RRMS 
will be included.  
o Free of relapse 30 days prior to task administration.  
o A Consultant Neurologist sub-specialising in MS will confirm diagnosis 
based on standardised investigation and in alignment with the revised 
McDonald [1] diagnostic criteria.  
o Expanded Disability Status Scale (EDSS) Score up to 6.5 [26].  
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Exclusion  
 Exclusion criteria for MS and Control participants:  
o MS subtype other than RRMS. 
o Presence of major psychiatric disorders e.g. severe depression. 
o History of neurodegenerative disease (other than MS) or brain injury.  
o Significant sensory deficits e.g. visual impairment. 
o Severe co-morbid health condition which is affecting motor abilities e.g. 
diabetes.  
 
(iii) Recruitment Procedures 
The researcher will meet with potential participants. All will be given an information 
sheet and research methodology will be fully outlined so participants will know 
exactly what will be expected of them in each task. Potential balance instability will 
also be explained and participants given the opportunity to try the BioSway system. 
Questions about participation will be answered at the meeting and throughout the 
research process. Participants will know that they can withdraw from the study at any 
time and all related data anonymised to meet data protection legislation. Participants 
will be given all the time they need to consider if they wish to participate or not. If they 
wish to, written consent forms will be provided.  
 
(iv) Measures 
Baseline Assessment  
 Demographic information: age, gender, education, disease type, onset and 
years of illness, mental health history.  
 Test of Premorbid Function (TOPF) [37] – measure of premorbid functioning.    
 Addenbrooke’s Cognitive Examination (ACE-III) [17] – a short cognitive test 
(designed to screen for dementia) will be utilised to assess general cognition.   
 Modified Fatigue Impact Scale (MFIS) [25] – self-report measure of fatigue.  
 Multiple Sclerosis Impact Scale (MSIS-29) [16] – quality of life measure  
 Hospital Anxiety and Depression Scale (HADS) [40] – screen for anxiety and 
depression.  
 Cortical Vision Screening Test (CORVIST) [19] – assesses visuoperceptual 
ability.  
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 Individual digit span assessments will be completed based on a method 
developed by Cocchini et al (2004). The administration of this approach will be 
altered from forward span to backward span to increase task difficulty.  
 
Divided Attention Questionnaire 
 DivA – Questionnaire measuring self-reported divided attention [15]. To be 
administered after baseline assessment and prior to task commencement.  
 
Balance Task  
 Individuals will stand on the BioSway [42] during tasks 2, 3, 4 and 5. 
Participants will also stand on a firm or unstable surface and asked to focus on 
keeping as still as possible. The unstable surface is foam and should therefore 
alter balance only minimally compared to firm surface. The primary measure 
derived from the BioSway will be centre of pressure (CoP). Balance measure 
will be calculated under single and dual-task conditions and dual-task 
decrement score calculated in terms of percentage change from single to 
dual-task conditions.  
 
Cognitive Task  
 Backwards digit span using a method developed by Cocchini et al (2004).  
 
(v) Design 
A between-subjects design will be utilised to compare balance and dual-tasking 
performance amongst MS and control participants within single and dual-task 
conditions. A within-subjects design will be used to examine the association between 
self-reported DivA scores and dual-tasking performance. All assessments will take 
place in the Neuropsychology clinic room, Raigmore Hospital or a clinic room in the 
RNI Community Hospital.  
 
(vi) Research Procedures  
Informed consent will be obtained from each participant. Firstly, demographic 
information will be collected then, to characterise the sample in terms of cognitive 
ability, all participants will complete baseline assessment measures and the DivA 
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questionnaire. Subsequently, all participants will undertake three single tasks and 
two dual-tasks. Task 1 involves participants completing a backward digit span task 
[8]. Task 2 requires participants to stand on a device, namely BioSway Portable 
Balance System (BioSway) [42], which measures an individual’s neuromuscular 
control and ability to balance on a firm or uneven surface. A firm surface will be used 
for task 2. Task 3 requires participants to stand on the BioSway device on an 
unstable surface. For task 4 participants will stand on the BioSway firm surface whilst 
completing the backwards-span task. Task 5 requires participants to stand on the 
BioSway unstable surface whilst completing the backwards-span task. To control for 
order effect, task order will be randomly assigned. There are many combinations task 
order could take; 5 have been selected for this study.  
  
(vii) Data Analysis  
Descriptive statistics will be produced to describe the data. Independent Samples T-
tests, Mann-Whitney U and Chi-Square tests will be used as appropriate to compare 
MS and control groups on demographic information, baseline clinical features, and to 
compare groups on single-task versus dual-task performance. Using Independent 
Samples T-tests and Mann-Whitney U-Tests as appropriate, measures of dual-task 
decrement (for balance and digit-span tasks) and collective dual-task decrement 
scores (average for combined balance and digit span tasks) for both groups will be 
compared. Spearman correlations will be used to examine whether there is a 
relationship between DivA scores and pooled dual-task decrement scores. Pearson 
Correlation coefficients (r) will be used to explore relationships between pre-morbid 
ability, cognition, self-reported anxiety and depression, fatigue, and dual-task 
decrement scores. Additionally, Pearson Correlation coefficients (r) will be used to 
examine disease severity (EDSS Score) and dual-task decrement scores in the MS 
group only.  
 
(viii) Justification of Sample Size 
Few studies have examined dual-tasking with balance/postural measures as 
outcomes. Kalron et al (2011) considered the effect of a cognitive task on postural 
control in individuals with a clinically isolated syndrome (CIS) suggestive of MS and 
control subject. They found that controls showed greater decrement from single to 
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dual-task conditions than PwMS, but a limitation of this study was the very mild 
sample hence unrepresentative of PwMS. Jacobs and Kasser (2012) reported that 
PwMS showed significantly greater decrement compared to controls on a postural 
task but provided insufficient data to calculate an effect size. Wajda, Motl and 
Sosnoff (2014) investigated the demographic, cognitive and clinical correlates of 
dual-task-cost of balance in PwMS but had no control group.  
 
In their study of gait under dual-task conditions, Hamilton et al (2009) found medium-
large effect sizes for a number of dual-task decrement measures (ranging from d=0.7 
to d=1.5). In the proposed study we have taken a number of approaches to try to 
maximise effect sizes, such as inclusion of a wider range of disability levels of MS 
participants and use of a backward digit span task which is more challenging than the 
previously used forward digit span tasks. However, given that the nature of the motor 
task is different from that used by Hamilton et al, we will take a conservative 
approach and power the proposed study on the basis of the lower of the effect sizes 
(d=0.7). So using G Power, with power set at 0.8, alpha at 0.05 (two-tailed), d=0.7, 
we find that a minimum of 34 participants per group are required. Following 
discussions with Consultant Neurologist colleagues, given the numbers of patients 
within the service, and taking into account the time needed to complete the research 
tasks we believe this number to be feasible.  
 
(ix) Settings and Equipment 
Setting 
Participants will be tested in the Neuropsychology room, Raigmore Hospital or where 
they were recruited e.g. MS Nurse Clinic, Inverness.  
 
Equipment 
 BioSway – created by Biodex Medical Systems Inc. [42]. Measures an 
individual’s neuromuscular control and ability to balance on firm and unstable 
surfaces.  
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Health and Safety Issues 
Researcher Safety Issues 
Researcher may need to physically support participants if feeling off balance. If at 
risk of falling the task will be stopped immediately. Participants will be given the 
opportunity to familiarise themselves with the BioSway prior to task administration 
and decide whether or not they would like to take part in the study.  
 
Participant Safety Issues 
As balance is being tested there is a possibility that participants may feel unsteady 
on their feet. The researcher will stand at their side and offer support if required. If 
participants are at risk of falling the task will be stopped immediately.  
 
*Further details of Health and Safety issues can be found in Appendix A  
 
Ethical Issues  
Ethical approval for the study will be sought from the West of Scotland Research 
Ethics. The project will be submitted to NHS Highland Research and Development 
Department for approval.   
 
Financial Issues 
 Printing of the Consent Form, Information Sheet, Demographic Information 
sheet, Diva Questionnaire, Cocchini digit span materials, ACE-III and MFIS for 
each participant  
 Contacting holder of copyright for copies of MSIS-29  
 Purchase of TOPF, HADS, CORVIST 
 
*Full details of expenses are outlined in Appendix B  
 
Timetable 
Ethical approval will, hopefully, be obtained by September 2015 with recruitment and 
the commencement of the study scheduled for October 2015.  
 
*Full timetable is outlined in Appendix C 
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Practical Applications 
If those with MS have increased difficulties with balance and dual-tasking it will be 
pertinent to incorporate this into clinical settings such as rehabilitation and 
Physiotherapy. Devising and implementing strategies around this area of difficulty to 
help individuals day-to-day will impact on symptom management and perhaps quality 
of life. Additionally, it is possible that DivA could be used across various clinical 
settings to support assessment of individuals with MS and inform aspects of 
treatment plans.  
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Proposal - Appendix A 
 
WEST OF SCOTLAND/ UNIVERSITY OF GLASGOW 
DOCTORATE IN CLINICAL PSYCHOLOGY 
 
HEALTH AND SAFETY FOR RESEARCHERS 
 
1. Title of Project 
 
An Investigation of Balance and Cognitive-Motor 
Dual-Tasking in Multiple Sclerosis  
 
2. Trainee Emma Butchard 
3. University Supervisor Prof. Jon Evans 
4. Other Supervisor(s) N.A. 
5. Local Lead Clinician Dr Jim Law and Dr Louise Blackmore 
6. Participants:  (age,  group or sub-
group, pre- or post-treatment, etc) 
Participants will be persons with a diagnosis of 
Relapsing Remitting MS (RRMS) (mild or moderate 
presentation) and control subjects matched for age 
and gender. It is estimated that 34 participants will 
be recruited for each group.  
7. Procedures to be applied  
(eg, questionnaire, interview, etc) 
 
 
 
 
Informed consent will be obtained from each 
participant. Firstly, demographic information will be 
collected then, to establish a sense of cognitive 
ability, all participants will complete baseline 
assessment measures and the DivA questionnaire. 
Subsequently, all participants will undertake three 
single tasks and two dual-tasks. Task 1 involves 
participants completing a backward digit span task 
(based on Cocchini et al, 2004).  Task 2 requires 
participants to stand on a device, namely BioSway 
Portable Balance System (BioSway) (Biodex 2015), 
which measures an individual’s neuromuscular 
control and ability to balance on a firm or unstable 
surface. A firm surface will be used for task 2. Task 
3 requires participants to stand on the BioSway 
device on an unstable surface. Task 4 necessitates 
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participants to stand on the BioSway firm surface 
whilst completing the backwards-span task. Task 5 
requires participants to stand on the BioSway 
unstable surface whilst completing the backwards-
span task. To control for order effect, task order will 
be randomly assigned. There are a multitude of 
combinations task order could take however, 5 have 
been selected for the purposes of this study.  
 
8. Setting (where will procedures be 
carried out?) 
i) General 
NHS Highland Neuropsychology Room, Raigmore 
Hospital or where the participant was recruited e.g. 
MS Nurse clinic in RNI hospital, Inverness.  
 ii) Are home visits involved  No 
 
9. Potential Risk Factors 
Identified  
   
 
As balance is being tested there is a possibility that 
participants may feel unsteady on their feet.  
. 10. Actions to minimise risk (refer 
to 9) 
 
 
 
 
 
 
1) Participants will be given the opportunity to 
familiarise themselves with the BioSway 
system prior to task administration and 
subsequently decide whether they are 
comfortable continuing to participate in this 
study or not.  
2) The researcher will stand at their side and 
offer support e.g. hand to help them step off 
BioSway, if required.  
3) If participants are at risk of falling the task 
will be stopped immediately 
 
Trainee signature:                                                        Date:  
 
University supervisor signature:            Date:  
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Proposal - Appendix B 
 
RESEARCH EQUIPMENT, CONSUMABLES AND EXPENSES  
 
Trainee: Emma Butchard  
Year of Course: 2nd year  
Intake Year: 2013 
 
Please complete the list below to the best of your ability 
 
 
Item 
 
Details and Amount 
Required 
 
Cost or Specify if to 
Request to Borrow from 
Department 
 
Stationary 
 
None 
 
Sub total: £0 
 
 
Postage 
 
 
None 
 
Sub total: £0 
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Photocopying and Laser 
Printing  (includes cost 
of white paper)  
 
Consent form - 1  
page x68 
 
Information sheet - 2 
pages (double-sided) x68 
 
 
Demographic information 
sheet - 1 page x68 
 
 
DivA Questionnaire – 1 
page x68 
 
 
Printing Cocchini Digit 
Span Material – 1 page 
x68  
 
 
Addenbrooke’s Cognitive 
Examination-III (ACE-III) 
– 3 pages x68 
 
 
 
Modified Fatigue Impact 
Scale (MFIS) – 3 pages 
x68 
 
Hospital Anxiety and 
Depression Scale 
(HADS): 1 page x68  
 
 
£3.40 
 
 
£3.40 
 
 
 
£3.40 
 
 
 
£3.40 
 
 
 
Not copyright.  
£3.40 
 
 
Copyright held by John 
Hodges who is happy for the 
test to be used clinically and 
for research projects [Hsieh, 
2012]. Print cost £10.20 
 
 
Not copyright.  
£10.20 
 
 
£3.40 
 
 
 
Subtotal: £40.80 
 
 
Equipment and Software 
 
 
 
 
BioSway 
 
 
Borrow from Glasgow 
University  
 
Subtotal: £0 
 
Measures 
 
 
 
The Multiple Sclerosis 
Impact Scale (MSIS-29) 
– 2 pages x68 
 
Test of Pre-morbid 
Functioning (TOPF): 68 
record forms 
 
 
Copyright. Publically available 
on MS Trust website.  
Printing cost: £6.80 
 
Copyright. Test provided by 
NHS Highland. 
Purchase cost: £0 
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Hospital Anxiety and 
Depression Scale 
(HADS): 68 record forms 
 
 
 
Cortical Vision Screening 
Test (CORVIST): 68 
record forms  
 
 
 
 
Copyright. License held by 
Professor Jon Evans to 
photocopy HADS.  
Purchase cost: £0 
 
 
Copyright. Borrowing manual 
and stimulus book from 
Glasgow University. Record 
forms sold in packs of 25 @ 
£18.50.  
Purchase cost: £55.50 
 
Subtotal:  £62.30 
 
 
Miscellaneous 
 
 
None 
 
Subtotal: £0 
Total  £103.10 
 
For any request over £200, please provide further justification for all items that 
contribute to a high total cost estimate: 
N/A 
 
 
 
Trainee Signature…………………………………… …   
 
Date……………………… 
 
 
Supervisor’s Signature ………………………………..     
 
Date ……………………… 
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Proposal - Appendix C 
 
MRP Research Timetable 
 
Date Task/Progress 
March 2015 Submit MRP proposal 
Submit cost form 
Submit Health & Safety Form 
April – September 2015 Research and Development approval 
Ethics approval 
Complete MRP supervision agreement 
Begin research logbook 
Recruit once approval gained 
October 2015 Commence study 
October 2015 – January 2016 Start data collection 
January – April 2016 Complete data collection 
May – July 2016 Draft MRP to supervisor May and 
finalised July 
July 2016 Loose bind and submit 
August 2016 Viva Preparation 
September 2016 Viva 
September – November 2016 Submit corrections (if required) 
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Appendix 2.10  
Divided Attention Questionnaire 
 
The following questions are about problems which everyone experiences from time to 
time, but some of which happen more often than others.  We want to know how often 
these things have happened to you in the last few weeks.  There are 5 options, ranging 
from very often to never, or not applicable.  Please tick the appropriate box. 
 
 Do you have any of these difficulties ..… Very 
often 
Quite 
often 
Occasio
nally 
Very 
rarely 
Never N/A 
D/K 
1 Paying attention to more than one thing at 
once?       
2 Needing to stop an activity to talk? 
      
3 Being unaware of others speaking to you when 
doing another activity? 
      
4 Following or taking part in a conversation 
where several people are speaking at once? 
      
5 Walking deteriorating when you are talking or 
listening to someone? 
      
6 Busy thinking your own thoughts, so not 
noticing what is going on around you? 
      
7 
Spilling a drink when carrying it.       
8 Spilling more if talking at the same time. 
      
9. 
Bumping into people or dropping things if 
doing something else as well? 
      
10
. 
Difficulty eating and watching television or 
listening to the radio at the same time. 
      
 
 Total in each category: 
x4 x3 x2 x1 x0 - 
 Subtotals: 
      
 
Sum of 4 subtotals =       ;     Divided by no. answered =    
Mean per question answered =  
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REF: Evans, J.J., Greenfield, E., Wilson, B.A., & Bateman, A. (2009). Walking and talking therapy: Improving cognitive–motor 
dual-tasking in neurological illness. Journal of the International Neuropsychological Society, 15, 112-120.  
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Appendix 2.12  
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Appendix 2.13  
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Appendix 2.14  
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